abdullah's picture
Add files using upload-large-folder tool
b4e65c0 verified
raw
history blame
71.2 kB
1
00:00:04,280 --> 00:00:08,880
ุจุณู… ุงู„ู„ู‡ ุงู„ุฑุญู…ู† ุงู„ุฑุญูŠู… ุณู†ุชูƒู„ู…
2
00:00:08,880 --> 00:00:11,320
ุงู„ูŠูˆู… ุงู† ุดุงุก ุงู„ู„ู‡ ููŠ ุงู„ู…ุญุงุถุฑุฉ ุงู„ุฑู‚ู… ุงุฑุจุน ุนู† ุงู„
3
00:00:11,320 --> 00:00:17,020
antibody structure and function ูˆุฏุนูˆู†ุง ู†ุณุชุฐูƒุฑ ุณูˆูŠุง
4
00:00:17,020 --> 00:00:22,900
ูŠุนู†ูŠ ู‡ุฐู‡ ุงู„ู…ุนู„ูˆู…ุงุช ู„ุงู† ุงู†ุง ุจุนุฑู ุงู† ุนู†ุฏูƒู… ุฎู„ููŠุฉ ุนู†
5
00:00:22,900 --> 00:00:29,720
ู‡ุฐุง ุงู„ู…ูˆุถูˆุน ูˆุฏุนูˆู†ุง ู†ุจุฏุฃ ุงู† ุดุงุก ุงู„ู„ู‡ ูˆุงุชู…ู†ู‰ ุงู† ุชูƒูˆู†
6
00:00:29,720 --> 00:00:34,420
ููŠ ู…ุนู„ูˆู…ุงุช ุฌูŠุฏุฉ ูˆุฌุฏูŠุฏุฉ ู„ูƒู…ุงู„ู…ู‡ู… ุงู„ู„ูŠ ุฃู‚ูˆู„ู‡ ุจุดูƒู„
7
00:00:34,420 --> 00:00:40,180
ุนุงู… ู‡ูˆ ุนุจุงุฑุฉ ุนู† antibody ุจูŠูˆุฌุฏ ุนู„ู‰ ุดุงูƒู„ุชูŠู† ููŠ
8
00:00:40,180 --> 00:00:45,840
ุงู„ุฌุณู… ุฅู…ุง secreted form ูˆุฅู…ุง membrane bound ุงู„
9
00:00:45,840 --> 00:00:52,980
membrane bound ู‡ูˆ ุนุจุงุฑุฉ ุนู† ุงู„ antibody ุงู„ู„ูŠ ู…ูˆุฌูˆุฏุฉ
10
00:00:52,980 --> 00:00:57,560
ุนู„ู‰ ุณุทุญ ุงู„ุจูŠู„ูŠู† ููŠ ุงู„ size ูˆุบุงู„ุจุง ู‡ุฐุง ุจูŠุดุชุบู„ ูƒ
11
00:00:57,560 --> 00:01:02,740
antigen receptor ุจูŠู†ู…ุง ุงู„ุจู„ุงุฒู…ุฉู‡ูŠ ุงู„ู„ู‰ ุจุชูุฑุฒ ุงู†ู‡ุง
12
00:01:02,740 --> 00:01:10,080
secreted form of antibody ุงู„ membrane bound ุบุงู„ุจุง
13
00:01:10,080 --> 00:01:14,760
associated with ูŠุนู†ูŠ cognate molecule ุงู„ู‡ูŠุชูŠุฑูˆ
14
00:01:14,760 --> 00:01:17,620
ุฏุงูŠู…ุฑ ู…ูˆู„ูŠูƒูˆู„ ุจูŠุณู…ูˆู‡ ุงู„ amino globulin alpha beta
15
00:01:17,620 --> 00:01:28,840
ูˆู‡ุฐุง ู‡ูˆ ู…ุน ุงู„ antibody ูŠุดูƒู„ ุจูŠุณ ุงู„ุฑุณุจุชูˆุฑ ุฏูˆู„ ุงู„
16
00:01:28,840 --> 00:01:32,480
amino globulin alpha betaู‡ูˆ ุงู„ู€ Intracellular
17
00:01:32,480 --> 00:01:37,000
Signaling Mechanism associated with B lymphocytes
18
00:01:37,000 --> 00:01:41,720
ุงู„ู€ Antibody ูƒู†ุง ุจู†ุนุฑู ุฃู†ู‡ ู„ู‡ Specificity ูˆู‡ูŠ ู„ู‡
19
00:01:41,720 --> 00:01:46,920
biological activity biological activity ุจุชุชู…ุซู„
20
00:01:46,920 --> 00:01:52,400
ุจุงู„ุขุชูŠ ุฃู†ู‡ it can neutralize the toxin immobilize
21
00:01:52,400 --> 00:01:56,260
the microorganism neutralization of viral
22
00:01:56,260 --> 00:02:00,860
infectivity agglutination of microorganism
23
00:02:01,870 --> 00:02:05,350
recipitation of soluble antigens ู‡ุฐู‡ ูƒู„ู‡ุง ุทุจุนุง
24
00:02:05,350 --> 00:02:10,710
ุงู„ูˆุธุงุฆู ุงู„ู…ูู‡ูˆู…ุฉ activation of serum complement
25
00:02:10,710 --> 00:02:15,890
ู„ุฃู†ู‡ ุจูŠู†ุดุท ุงู„ complement to facilitate lysis of
26
00:02:15,890 --> 00:02:20,070
microorganism ุญุตู„ุชู‡ุง lysis of microorganism
27
00:02:20,070 --> 00:02:23,630
ability to cross the placenta ููŠ ุจุนุถู‡ุง ุจูŠุนู…ู„
28
00:02:23,630 --> 00:02:27,970
crossing ู„ู„ placenta ูˆ from mother to the fetus
29
00:02:30,790 --> 00:02:33,730
ุงู„ุงุฎุชู„ุงู ููŠ ุงู„ู€ biological activity ูˆููŠ ุงู„ู€
30
00:02:33,730 --> 00:02:38,410
antibody ู‡ูŠ
31
00:02:38,410 --> 00:02:43,590
ุงู„ู„ูŠ ุจุชุณุงู‡ู… ุงูˆ ุจุชุดูƒู„ู†ุง ุงู„ isotypic class structure
32
00:02:43,590 --> 00:02:52,250
isotypic class structure ูˆ ุงู„ antibody molecule ู…ุง
33
00:02:52,250 --> 00:02:56,250
ุจูŠุชุฑูƒุฒ ููŠ ุงู„ุฌุงู…ุนุฉ global infraction ุงู„ู„ูŠ ู„ูˆ ุนู…ู„ู†ุง
34
00:02:56,250 --> 00:03:04,420
protein electrophoresis ู‡ู†ู„ุงู‚ูŠุฅู†ู‡ ุฃุฏูˆู‰ ุงู„
35
00:03:04,420 --> 00:03:08,780
Electrophoresis ุงู„ู„ู‰ ุจูŠุชู…ุซู„ ุจุงู„ู‚ุงุชู‰ ู‡ุฐุง ุทุจุนุง
36
00:03:08,780 --> 00:03:13,820
abnormal protein Electrophoresis ู„ myeloma patient
37
00:03:13,820 --> 00:03:18,300
ู„ูƒู† ุนุดุงู† ู†ุนุฑู ุจุณ ุงู„ุฃูˆุถุงุน ู‡ุฐุง ุงู„ album ุงู†ู‡ ููŠ ูƒู…ุงู†
38
00:03:18,300 --> 00:03:27,300
ูˆุงุญุฏุฉ ู‡ู†ุง pre album spike ุซู… Alpha Globulin ูˆ
39
00:03:27,300 --> 00:03:33,150
Alpha 2 GlobulinุจูŠุชุง ุฌู„ูˆุจูŠู„ูŠู† ูˆ ุฌุงู…ุง ุฌู„ูˆุจูŠู„ูŠู† ููŠ
40
00:03:33,150 --> 00:03:38,350
ุงู„ุฌุงู…ุง ุฌู„ูˆุจูŠู„ูŠู† ู‡ูˆ ุงู„ู„ูŠ ู…ูˆุฌูˆุฏ ุจูŠุดูƒู„ู†ุง ุงู„ antibody
41
00:03:38,350 --> 00:03:41,370
ุงู„
42
00:03:41,370 --> 00:03:47,990
structure mainly ุฒูŠ ู…ุง ุงู†ุชูˆุง ุดุงูŠููŠู† ุจูŠู…ุฑ
43
00:03:47,990 --> 00:03:57,130
ููŠ ู…ุฑุญู„ุชูŠู† ู…ุฑุญู„ุฉ ุงู„ pre B cell receptor ูŠุนู†ูŠ ุงู„
44
00:03:57,130 --> 00:04:04,490
precursor ูŠุนู†ูŠ ุงู„ุฌุจู„ ู…ุง ูŠุชูƒูˆู† ุงู„ PCR ูˆ ุงู„ PCR ุทุจุนุง
45
00:04:04,490 --> 00:04:10,710
ููŠ ุงู„ Pre-B ู‡ูˆ ุงู„ู„ู‰ ุบุงู„ุจุง ุจุชูƒูˆู† ุงู„ ุงู„ ุงู„ Hevet
46
00:04:10,710 --> 00:04:17,890
Chain ู‡ูŠ ุนู…ุฑู‡ุง ุงู„ Mu Chain ูˆ ุงู„ ุจุนุฏ ู‡ูŠูƒ ุงู„ Hevet
47
00:04:17,890 --> 00:04:23,150
Chain ู…ู…ูƒู† ุชุชุจุฏู„ ูˆ ุชุตูŠุฑ Mu ุงูˆ Delta ุงูˆ Gamma ุงูˆ
48
00:04:23,150 --> 00:04:29,270
Alpha ุงูˆ Y ููŠ ุญุงู„ุฉ ุงู„ PCR ูˆ Structurallyุทุจุนุง ููŠ
49
00:04:29,270 --> 00:04:33,190
ู…ุตุทู„ุญ ุงู† ุดุงุก ุงู„ู„ู‡ ู‡ู†ุชุทู„ู‚ ุงู„ูŠู‡ ู‚ุฏุงู… ุงู„ู„ูŠ ู‡ูˆ ุงู„
50
00:04:33,190 --> 00:04:37,810
immunoreceptor tyrosine based activation motif
51
00:04:37,810 --> 00:04:43,610
ุงู„ู„ูŠ ุงู† ุดุงุก ุงู„ู„ู‡ ู‡ู†ุชุทู„ู‚ ุงู„ูŠู‡ ุฒูŠ ู…ุง ุงู†ุชูˆุง ุดุงูŠููŠู† ุงู„
52
00:04:43,610 --> 00:04:51,490
structure ุฏู‡ ููŠ ุงู„ pre-b ุฏู‡ ู‡ูˆ ุจูŠุชูƒูˆูŠู† ู…ู† lighted
53
00:04:51,490 --> 00:04:54,610
chain ูˆ ู…ู† heavy chain connected to each other by
54
00:04:54,610 --> 00:04:59,500
disulfide bondูˆ Lighted Chain ู…ู…ูƒู†ุฉ ุนู„ู‰ ุณุจูŠู„
55
00:04:59,500 --> 00:05:03,080
ุงู„ู…ุซุงู„ ุงู†ู‡ุง ู†ูˆุน Delta ู„ุงู† ุณู†ุดุงู‡ุฏ ุงู†ู‡ุง ู…ู…ูƒู† ุชูƒูˆู†
56
00:05:03,080 --> 00:05:06,540
ูƒุนุจุฉ ุงูˆ Delta ูˆLeft Chain ู‡ุฐุง ุฒูŠ ู…ุง ุงู†ุชูˆุง ุดุงูŠููŠู†
57
00:05:06,540 --> 00:05:13,200
ู‡ูŠ ุนุจุงุฑุฉ ุนู† Mu Chain ุฌู†ุจ ุงู„ structure ู‡ุฐุง ูˆ ู‡ุฏู
58
00:05:13,200 --> 00:05:16,560
ุงู„ููŠุฌุฑ ู‡ุฐุง ุงู†ู‡ ู†ูˆุฑุฌูƒูˆุง ุงู„ Immunoglobulin Alpha
59
00:05:16,560 --> 00:05:21,140
Immunoglobulin Beta ู…ูˆู„ูŠูƒูŠูˆู„ ู‡ุฐุง ู‡ูˆ ุฌู†ุจู‡ ูˆ ู‡ุฐุง ู‡ูˆ
60
00:05:21,140 --> 00:05:26,200
ู…ุบุฑูˆุฒ ููŠ ุฏุงุฎู„ ุงู†ู‡ IntracytoplasmicDomain ุฃูˆ
61
00:05:26,200 --> 00:05:33,640
Membrane ุฃูˆ Domain ูˆ ู‡ุฐุง ุงู„ู€ Intracytoplasmic
62
00:05:33,640 --> 00:05:37,640
portion ู‡ูˆ ุงู„ู…ุณุคูˆู„ ุนู† Cell Signaling ุงู„ู…ูˆู„ูŠูƒูŠูˆู…
63
00:05:37,640 --> 00:05:41,420
ุทุจุนุง ูƒู…ุง ุชุดูˆููˆู† ุฏูˆู†ุง ููŠ ุนู†ุฏู†ุง Antigen Binding
64
00:05:41,420 --> 00:05:45,420
ูˆุนู†ุฏู†ุง ู‡ู†ูŠุฌูŠ ุนู„ู‰ Structure ุจุดูŠุก ู…ู† ุงู„ุชูุตูŠู„
65
00:05:45,420 --> 00:05:48,840
Structure
66
00:05:48,840 --> 00:05:54,790
of light and heavy chain ุฏู‡ ู‡ู…ุทุจุนุง ุงู„ structure of
67
00:05:54,790 --> 00:05:59,570
light ุงูˆ ุงู„ heavy chain ู‡ุฐูŠ light chain ูˆู‡ุฐู‡ heavy
68
00:05:59,570 --> 00:06:02,770
chain connected to each other by disulfide bond ู‡ูŠ
69
00:06:02,770 --> 00:06:06,830
disulfide bond ุดูˆุงู† ูƒุงู†ุช ุงู„ light ู…ุน ุงู„ heavy ุงูˆ
70
00:06:06,830 --> 00:06:10,670
ุงู„ heavy ู…ุน ุงู„ heavy ููŠ disulfide bond ู…ูˆุฌูˆุฏุฉ ูƒูŠู
71
00:06:10,670 --> 00:06:17,370
ุชุนุฑู ุนู† ุงู„ structure ofุจุงู„ุชุงู„ูŠ ุงุณุชุฎุฏู…ูˆุง ุชู‚ุงุทุน
72
00:06:17,370 --> 00:06:23,590
ุงู„ู…ูˆู„ูŠูƒูŠูˆู„ ุงู„ุงู†ุชูŠุจุงุฏูŠ ู…ู‚ุงูˆู… ู„ู„ุจุฑูˆุชูŠูˆู„ุงูŠุฒูŠุฒ
73
00:06:25,020 --> 00:06:29,180
ุจุฅู…ูƒุงู†ูŠุฉ ุชู‚ุทูŠุนู‡ ุจูˆุงุณุทุฉ two enzymes ูˆุงุญุฏ ุงุณู…ู‡
74
00:06:29,180 --> 00:06:32,900
papine ูˆุงุญุฏ ุงุณู…ู‡ pepsin ุงู„ papine ุจูŠู‚ุทุน ุงู„
75
00:06:32,900 --> 00:06:38,720
antibody ู„ุชู„ุช ุฃุฌุฒุงุก ุชูˆูู‰ ุจ fragment ูˆุงุญุฏุฉ FC ุจูŠู†ู…ุง
76
00:06:38,720 --> 00:06:44,320
ุงู„ pepsin ุฒูŠ ู…ุง ุงู†ุชูˆุง ุดุงูŠููŠู† ุจูŠู‚ุทุน ุงู„ fragment ุงู„
77
00:06:44,320 --> 00:06:48,200
antibody immunoglobul ู„ุชุซู‚ูŠู† ุฌุฒุก ูƒุจูŠุฑ ุงู„ู„ูŠ ู‡ูˆ
78
00:06:48,200 --> 00:06:56,910
ุนุจุงุฑุฉ ุนู†ุชูˆูุจ ู…ุน ุจุนุถ ูˆ Fc prime ุจูŠุณู…ูˆู‡ุง ุงูˆ Fc sub
79
00:06:56,910 --> 00:07:03,690
fragment ูƒู…ูŠุฉ ู‚ู„ูŠู„ุฉ ู…ู† ุงู„ Fc portion structure
80
00:07:03,690 --> 00:07:10,470
ู‡ุฐุง ุจุดูƒู„ ุนุงู… ู„ุงู† ู‡ู†ุฌุฏ ุงู† ุดุงุก ุงู„ู„ู‡ ู„ูุฉ ูุตูŠู„ุชู‡ ู‡ูŠ ุงู„
81
00:07:10,470 --> 00:07:13,370
heavy chain ุงุฑุจุนุฉ polypeptide ู„ุชูƒูˆู† ุงุฑุจุนุฉ
82
00:07:13,370 --> 00:07:20,450
polypeptide chain ุชู†ุชูŠู† heavy ู‡ุฐุง ู‡ู…ูˆ ุชู†ุชูŠู† light
83
00:07:20,450 --> 00:07:25,090
ู‡ุฏู‰ light ูˆ ู‡ุฏู‰ light they are connected to each
84
00:07:25,090 --> 00:07:29,550
other by whatุŸ by disulfide bond ูู‰ ุงู†ู‡ุง ู†ูˆุนูŠู† ู…ู†
85
00:07:29,550 --> 00:07:34,390
ุงู„ disulfide ูู‰ ุงู†ุชุฑุง disulfide bond ูˆ ุฏู‡ ู‡ูŠ ุฒู‰ ู…ุง
86
00:07:34,390 --> 00:07:40,090
ุงู†ุชูˆุง ุดุงูŠููŠู† ูˆ ูู‰ ุงู†ุชุฑ disulfide bond ุงู„ู„ู‰ ุจุชุชุฑุจุท
87
00:07:40,090 --> 00:07:45,790
ุงู„ two of eachูŠู† ู…ุน ุจุนุถ ุงู„
88
00:07:47,790 --> 00:07:50,750
Properties of the chain ุงู„ู€ Light ุชุชูƒูˆู‘ู† ู…ู† ุงู„ู€
89
00:07:50,750 --> 00:07:57,970
two domains VL ูˆCL Light ุจุฑู…ุฌูˆู„ู‡ุง ุจู‚ู‰ Light ุงู„
90
00:07:57,970 --> 00:08:01,930
Light ุจุฑู…ุฌูˆู„ู‡ุง ุจู‚ู‰ L ูˆู‡ูŠ ุชุชูƒูˆู‘ู† ู…ู† ุงู„ two domains
91
00:08:01,930 --> 00:08:06,590
ูˆุงุญุฏ variable ูˆุงุญุฏ constant ุจูŠู†ู…ุง ุงู„ Heavy ุชุชูƒูˆู‘ู†
92
00:08:06,590 --> 00:08:13,170
ู…ู† ุงูƒุชุฑ ู…ู† domain ูˆุงุญุฏ ู…ู†ู‡ู… variable ุจูŠุณู…ูˆู‡ VH
93
00:08:13,630 --> 00:08:19,430
ูˆุงู„ุจุงู‚ูŠ constant ูููŠ ุนู†ุฏู†ุง CH ูˆุงุญุฏ ูˆ CH ุงุชู†ูŠู† ูˆ CH
94
00:08:19,430 --> 00:08:29,270
ุชู„ุงุชุฉ ุนู†ุฏ ุงู„ .. ุงู„ .. ุงู„ heavy chain are
95
00:08:29,270 --> 00:08:40,310
connected ูŠุนู†ูŠ by region ุจูŠุณู…ูˆู‡ุง hinge region ูˆ ุงู†
96
00:08:40,310 --> 00:08:44,080
ุดุงุก ุงู„ู„ู‡ ู‡ู†ุชุทู„ู‚ ู„ูˆุธูŠูุชู‡ุง ุงู„ุขู†ุงู„ู„ูŠ ุงุฑูŠุฏ ุงู† ุชุดุงู‡ุฏูˆุง
97
00:08:44,080 --> 00:08:49,080
ุงู„ุงู† ุงู† ุงู„ VH ูˆุงู„LH ูŠูƒูˆู†ูˆุง ุงู„ุงู†ุชุฌุฑูŠู† ุจุงูŠู†ุฏุฑูŠู†ุฌ
98
00:08:49,080 --> 00:08:55,080
ุณุงูŠุณ ูˆุงู„ุจุงู‚ูŠ ูŠูƒูˆู† ุงู„ Fc ุจูˆุฑุดูŠู† ููŠ ุงู„ biological
99
00:08:55,080 --> 00:08:56,060
activity
100
00:09:01,850 --> 00:09:06,650
ู…ุงุดูŠ ุงุชูู‚ู†ุง ุงู† ุงู„ ุจูŠุงุจูŠู† ุฏู‡ ู‡ูˆ ู‚ุณู…ู‡ ุงู„ู‰ two FAB
101
00:09:06,650 --> 00:09:13,250
FAB ุฒุงุฆุฏ FAB ุฒุงุฆุฏ FC ูˆ ุงู„ FAB fragment ูƒุงู† ุจูŠุงู†ุฏ
102
00:09:13,250 --> 00:09:19,770
ุงู†ุชุฌูŠู† ุนุงุฏูŠ ุฌุฏุง ู„ูƒู†ู‡ุง ู…ุงุจุชุนู…ู„ precipitation ู„ุฃู†ู‡ุง
103
00:09:19,770 --> 00:09:25,110
univalent ู…ุงุดูŠ ูˆ ุงู„ FC portion ุงุชูู‚ู†ุง ุงู†ู‡ุง ู‡ูŠ
104
00:09:25,110 --> 00:09:30,070
ุงู„ู…ุณุคูˆู„ุฉ ุนู† ุงู„ biological activity ู„ูˆ ุนู…ู„ู†ุง ุงู„
105
00:09:30,070 --> 00:09:35,770
antibodyุจุงู„ู€ mercaptoethanol ุงู„ู€ mercaptoethanol
106
00:09:35,770 --> 00:09:43,010
ู‡ูŠู‚ุทุน ุงู„ุงุณุงุณ bond ูˆูŠุฏูŠู†ุง four chain ุฒูŠ ู…ุง ุงุชูู‚ู†ุง
107
00:09:43,010 --> 00:09:48,730
two light ูˆ two heavy ุงู„ antibody ุจูŠุชูƒูˆู† ู…ู† ุฃุฑุจุน
108
00:09:48,730 --> 00:09:52,870
polyp ุจุชุงุนูŠ two light ูˆ two heavy ูˆ ุทุจุนุง they are
109
00:09:52,870 --> 00:09:56,650
linked to each other by disulfide bond ุงู„ู„ูŠ ูƒู…ุงู†
110
00:09:56,650 --> 00:10:00,710
ู‚ู„ู†ุง ุงู† ุงู„ pepsin digest the M-unoglobulin
111
00:10:03,940 --> 00:10:10,060
ูˆุงู„ู…ุญุตู„ุฉ Divalent Fragment ุงุณู…ู‡ุง FAB ุงู„ูƒู„ 2 ุชุชูƒูˆู‘ู†
112
00:10:10,060 --> 00:10:14,660
ู…ู† Two Fabregion ู…ุฑุชุจุทูŠู† ู…ุน ุจุนุถ By Disulfide Bond
113
00:10:14,660 --> 00:10:20,240
in addition to the Fc Subfragment ุงู„ู„ูŠ ู‡ูŠ ุนุจุงุฑุฉ ุนู†
114
00:10:20,240 --> 00:10:25,440
ุฃู‚ู„ ู…ู† Fragment ูˆุทุจุนุง ุจุฑู…ุฌูˆู„ู‡ุง ููŠ ุจุนุถ ุงู„ูƒุชุจ ุจุงู„ู€
115
00:10:25,440 --> 00:10:30,140
Fc Prime Other molecule belonging to the
116
00:10:30,140 --> 00:10:31,820
immunoglobulin superfamily
117
00:10:35,070 --> 00:10:38,790
Sharing with the immunoglobulin structure ูˆุงุญู†ุง
118
00:10:38,790 --> 00:10:44,390
ู‡ุชุชุฑู‚ ุงู† ุดุงุก ุงู„ู„ู‡ ุนุงุฏูŠู‡ู… ุงู„ lighted chain ุบุงู„ุจุง
119
00:10:44,390 --> 00:10:49,830
ุจุชูƒูˆู† ูŠุง ุงู…ุง ูƒุงุจุง ูŠุง ุงู…ุง lambda ูˆุญุณุจ ุงู„ structure
120
00:10:49,830 --> 00:10:53,610
of heavy chain ูŠุนู†ูŠ ุงู„ heavy chain ู‡ูŠ ู…ุณุฆูˆู„ุฉ ุนู†
121
00:10:53,610 --> 00:10:58,290
ุชูƒูˆูŠู† ุงู„isotypes ุงูˆ ุงู„ classes of immunoglobulin
122
00:10:59,690 --> 00:11:08,550
ูˆู†ุฌุฏ ุงู† ุงู„ู‡ูŠูˆุชุดูŠู† ุชุฎุชู„ู ู…ู† ูˆุงุญุฏ ู„ุชุงู†ูŠ ุจุงุฎุชู„ุงู
123
00:11:08,550 --> 00:11:13,510
ุงู„ุงู†ุชุฌูŠู† ูˆุชุญุชูˆูŠ ุนู„ู‰ ู…ูˆุงุตู„ุฉ ุงู„ูƒุฑุจูˆู‡ูŠุฏุฑุงุช ูˆู…ุฑูƒุฒู‡ุง
124
00:11:13,510 --> 00:11:19,250
ุจุดูƒู„ ุนุงู… ูƒุฑุจูˆู‡ูŠุฏุฑุงุช ููŠ ู…ู†ุทู‚ุฉ ุงู„ู‡ูŠูˆุชุดูŠู† ูˆุชุฎุชู„ู ุฃูŠุถุง
125
00:11:19,250 --> 00:11:28,810
ููŠ ุตู…ูŠู…ู‡ุง ู…ุง ุจูŠู†ู‡ุง ูˆุงูŠุถุง ู‡ู†ุงูƒ ุงุฎุชู„ุงูุงุชIn
126
00:11:28,810 --> 00:11:36,590
biological function on each isotype ู„ุฅู† ุงูŠ one
127
00:11:36,590 --> 00:11:43,210
antibody molecule ููŠ ุนู†ุฏู†ุง ุงู„ู‡ูŠู„ูˆุฌูŠู† which are
128
00:11:43,210 --> 00:11:48,210
identical ูุนู„ู‰ ุณุจูŠู„ ุงู„ู…ุซุงู„ ููŠ ุงู„ immunoglobulin
129
00:11:48,210 --> 00:11:55,230
class ููŠ ุนู†ุฏู†ุง ุงู„ structure ุจูŠูƒูˆู† Kappa 2 Gamma 2
130
00:11:55,230 --> 00:12:01,510
ูˆLambda 2 Gamma 2TWO IDENTICAL LIGHTED CHAIN AND
131
00:12:01,510 --> 00:12:06,290
TWO IDENTICAL HEAVY CHAIN ุจุนุถ ุงู„ู€ Immunoglobulin
132
00:12:06,290 --> 00:12:11,670
subclasses ุฒูŠ ุงู„ IGG ุงู„ูˆ subclasses
133
00:12:11,670 --> 00:12:18,330
ูˆ IGG ุงู„ูˆ ุฃุฑุจุน subclasses ุณู…ูˆู‡ู… immunoglobulin 1
134
00:12:18,330 --> 00:12:25,430
IGG 1 ูˆ 2 ูˆ 3 ูˆ 4 ุฃูŠุถุง ุงู„ immunoglobulin A ุงู„ูˆ two
135
00:12:25,430 --> 00:12:31,540
subclasses IGA ูˆ IG2ุจุนุถ ุงู„ู…ุฏุงุฑุณ ุงู„ุชูŠ ุชุฎุชู„ู ุนู†
136
00:12:31,540 --> 00:12:38,380
ุงู„ู…ุฏุงุฑุณ ู‡ูŠ ุงู†ู‡ุง ุชุฎุชู„ู ููŠ ุฑู‚ู…ู‡ุง ูˆู…ุฌู…ูˆุนุฉ ุงู„ู€ Inter
137
00:12:38,380 --> 00:12:43,180
-Chain Disulfide Bond ูˆุจุนุถ ุงู„ุฅุฎุชู„ุงูุงุช ููŠ ุงู„ู€
138
00:12:43,180 --> 00:12:49,500
Structure ุงู„ู€ Light Chain ุจุชุญุชูˆูŠ ุนู„ู‰ 2 Domain
139
00:12:49,500 --> 00:12:53,040
Globular Domain ูˆLeft Chain ุจุชุญุชูˆูŠ ุนู„ู‰ 4 ุฃูˆ 5
140
00:12:53,040 --> 00:12:54,260
Domain
141
00:13:00,310 --> 00:13:05,190
ู‡ูŠุจุชุดูŠู† ูŠุชูˆุญูƒ ุนู„ูŠู‡ุง ู…ู† ุฎู„ุงู„ ู‚ุทุน ู‚ุทุน ู‚ุทุน ู‚ุทุน ู‚ุทุน
142
00:13:05,190 --> 00:13:05,670
ู‚ุทุน ู‚ุทุน ู‚ุทุน ู‚ุทุน ู‚ุทุน ู‚ุทุน ู‚ุทุน ู‚ุทุน ู‚ุทุน ู‚ุทุน ู‚ุทุน ู‚ุทุน
143
00:13:05,670 --> 00:13:06,350
ู‚ุทุน ู‚ุทุน ู‚ุทุน ู‚ุทุน ู‚ุทุน ู‚ุทุน ู‚ุทุน ู‚ุทุน ู‚ุทุน ู‚ุทุน ู‚ุทุน ู‚ุทุน
144
00:13:06,350 --> 00:13:06,810
ู‚ุทุน ู‚ุทุน ู‚ุทุน ู‚ุทุน ู‚ุทุน ู‚ุทุน ู‚ุทุน ู‚ุทุน ู‚ุทุน ู‚ุทุน ู‚ุทุน ู‚ุทุน
145
00:13:06,810 --> 00:13:07,090
ู‚ุทุน ู‚ุทุน ู‚ุทุน ู‚ุทุน ู‚ุทุน ู‚ุทุน ู‚ุทุน ู‚ุทุน ู‚ุทุน ู‚ุทุน ู‚ุทุน ู‚ุทุน
146
00:13:07,090 --> 00:13:08,110
ู‚ุทุน ู‚ุทุน ู‚ุทุน ู‚ุทุน ู‚ุทุน ู‚ุทุน ู‚ุทุน ู‚ุทุน ู‚ุทุน ู‚ุทุน ู‚ุทุน ู‚ุทุน
147
00:13:08,110 --> 00:13:08,110
ู‚ุทุน ู‚ุทุน ู‚ุทุน ู‚ุทุน
148
00:13:21,380 --> 00:13:24,980
ุงู„ู„ูŠ ู‡ูˆ domain ููŠ ุงู„ู€ heavy ูˆููŠ ุงู„ light is highly
149
00:13:24,980 --> 00:13:29,820
variable ููŠ ุชุฑูƒูŠุจุชู‡ ู…ู† ู†ุงุญูŠุฉ amino acid sequence
150
00:13:29,820 --> 00:13:35,940
ูˆุจูŠุฎุชู„ู from one antibody to the next ูˆุจูŠุฑู…ุฒูˆู„ู‡ู…
151
00:13:35,940 --> 00:13:43,500
VL ูŠุนู†ูŠ variable light or VH ูŠุนู†ูŠ variable heavy
152
00:13:43,500 --> 00:13:50,120
the second and subsequent domainููŠ ุงู„ู€ Heavy ูˆููŠ
153
00:13:50,120 --> 00:13:55,260
ุงู„ู€ Light Chain ู‡ู…ุง ู…ุณุชู…ุฑูŠู† ุจุฑู…ุฒ
154
00:13:55,260 --> 00:13:58,920
CLCH1 ูˆ CH1 ูˆ CH1 ูˆ CH1 ูˆ CH1 ูˆ CH1 ูˆ CH1 ูˆ CH1 ูˆ
155
00:13:58,920 --> 00:14:04,320
CH1 ูˆ CH1 ูˆ CH1 ูˆ CH1 ูˆ CH1 ูˆ CH1 ูˆ CH1 ูˆ CH1 ูˆ
156
00:14:04,320 --> 00:14:06,500
CH1 ูˆ CH1 ูˆ CH1 ูˆ CH1 ูˆ CH1 ูˆ CH1 ูˆ CH1 ูˆ CH1 ูˆ
157
00:14:06,500 --> 00:14:06,500
CH1 ูˆ CH1 ูˆ CH1 ูˆ CH1 ูˆ CH1 ูˆ CH1 ูˆ CH1 ูˆ CH1 ูˆ
158
00:14:06,500 --> 00:14:06,500
CH1 ูˆ CH1 ูˆ CH1 ูˆ CH1 ูˆ CH1 ูˆ CH1 ูˆ CH1 ูˆ CH1 ูˆ
159
00:14:06,500 --> 00:14:06,500
CH1 ูˆ CH1 ูˆ CH1 ูˆ CH1 ูˆ CH1 ูˆ CH1 ูˆ CH1 ูˆ CH1 ูˆ
160
00:14:06,500 --> 00:14:06,500
CH1 ูˆ CH1 ูˆ CH1 ูˆ CH1 ูˆ CH1 ูˆ CH1 ูˆ CH1 ูˆ CH1 ูˆ
161
00:14:06,500 --> 00:14:07,700
CH1 ูˆ CH1 ูˆ CH1 ูˆ CH1 ูˆ CH1 ูˆ CH1 ูˆ CH1 ูˆ CH1 ูˆ
162
00:14:07,700 --> 00:14:18,670
CH1 ูˆ CH1 ูˆ CH1 ูˆby hydrophobic interaction as
163
00:14:18,670 --> 00:14:26,850
follows ูุจู†ู„ุงุญุธ ุงู†ู‡ ููŠ ุนู†ุฏู†ุง VH LH ูŠุนู†ูŠ V heavy ู…ุน
164
00:14:26,850 --> 00:14:33,650
light heavy ูˆ CH ูˆุงุญุฏ ู…ุน ุงู„ constant ุชุจุน ุงู„ light
165
00:14:33,650 --> 00:14:37,170
ุซู… ุจุชุจุฏุฃ ุงู„ constant ุจุชุงุนุฉ ุงู„ heavy ุจุชุฑุชุจุท ู…ุน ุจุนุถ
166
00:14:37,170 --> 00:14:42,390
constant V2 ู…ุน constant V2 ูˆ constant V3 ู…ุน
167
00:14:42,390 --> 00:14:44,290
constant V3
168
00:14:48,990 --> 00:14:52,530
ุงู„ู€ Hedge region ุฒูŠ ู…ุง ุงุชูู‚ู†ุง ู‡ูŠ ุนุจุงุฑุฉ ุนู† ู†ุทู‚ุฉ
169
00:14:52,530 --> 00:14:57,610
unfolded ุจุณู…ูˆู‡ุง region composed of short segments
170
00:14:57,610 --> 00:15:04,690
of amino acids ุบุงู„ุจุง ู‡ูŠ ุงู„ุชูŠ ุชูุตู„ ู…ุง ุจูŠู† CH1 ูˆ CH2
171
00:15:04,690 --> 00:15:12,850
region ูˆู…ู„ูŠุงู†ุฉ ุจุงู„ cysteine and bromine residue ูˆ
172
00:15:12,850 --> 00:15:16,170
ุงู„ cysteine ู‡ูˆ ุงู„ู…ุณุฆูˆู„ ุนู† ุงู„ formation of
173
00:15:16,170 --> 00:15:22,630
interchain disulfide bondูˆุงู„ุจุฑูˆู„ูŠู† ุฑูŠุฒูŠุฌูŠูˆ ุจูŠู…ู†ุน
174
00:15:22,630 --> 00:15:32,530
ุงู„ู„ูŠ ู‡ูˆ ุงู„ุงุชูุงู ุงู„ structure of heavy chain in
175
00:15:32,530 --> 00:15:39,030
globular form ุจูŠุจู‚ู‰ ุงู„ู…ูˆุฌูˆุฏ ุจู†ูุณ ุงู„ู†ู…ุท ุงูŠุถุง ู…ู†
176
00:15:39,030 --> 00:15:46,270
ุตูุงุชู‡ุง ุงู†ู‡ุง ุจุชูƒุณุจ ุงู„ antibody flexibility ูˆุฎุตูˆุตุง
177
00:15:47,060 --> 00:15:50,740
ููŠ ุงู„ู€ Fab region ูุจุงู„ุชุงู„ูŠ ุจุชุชุญุฑูƒ freely ุงู„ Fab
178
00:15:50,740 --> 00:15:55,900
region in the Y-shape ูˆู‡ุฐุง ุจูŠู…ูƒู†ู‡ุง ุจูŠู…ูƒู† ุงู„ุทูˆูุฉ
179
00:15:55,900 --> 00:16:04,300
ุงู†ู‡ู… ูŠูุชุญูˆุง ูˆ ูŠุณูƒุฑูˆุง ู„ูŠุชูƒูŠููˆุง ุญุณุจ ุงู„ุงุฑุชุจุงุท ู…ุน two
180
00:16:04,300 --> 00:16:10,500
Epitopes ู…ูˆุฌูˆุฏูŠู† ุนู„ู‰ ุณุทุญ Antigen ุงู† ูƒุงู†ูˆุง ุจุนุฏ ุงู„
181
00:16:10,500 --> 00:16:16,210
two Epitopes ุงูˆ ุงุฌุฑุงุจ ุงู„ุงู„ู€ Fabregion ุจุชูุชุญ ูˆ
182
00:16:16,210 --> 00:16:21,930
ุจุชุณูƒุฑ ุนุดุงู† ุชู…ุณูƒู„ูŠ ููŠ ู‡ุฏูˆู„ ุงู„ุชู†ุชูŠู† Variable Region
183
00:16:21,930 --> 00:16:25,050
ุญุงู„ุฉ
184
00:16:25,050 --> 00:16:26,870
ุจุฏู†ุง ู†ุญูƒูŠ ุนู† ุงู„ Variable Region ููŠ ุงู„ู€ left and
185
00:16:26,870 --> 00:16:31,830
left chain ุฌุงู„ู‡ ุจุชุชูƒุงู…ู† ู…ู† 110 amino acids ูˆ
186
00:16:31,830 --> 00:16:36,690
ุจุชุญุชูˆูŠ ุนู„ู‰ three regions ุจูŠุณู…ูˆู‡ู… Hypervariable
187
00:16:36,690 --> 00:16:42,070
Region ูˆ ุงู„ Hypervariable Region ู‡ูŠ ุงู„ู…ุณุฆูˆู„ุฉ ุนู† ุงู„
188
00:16:42,070 --> 00:16:43,030
antigen binding
189
00:16:45,950 --> 00:16:50,630
ุจุชูƒูˆู† ุญุงุฌุฉ ุจูŠุณู…ูˆู‡ุง complementary structure to the
190
00:16:50,630 --> 00:16:55,210
antigen epitope ูŠุนู†ูŠ ู…ูƒู…ู„ ู…ุง ุงุญู†ุง ุนุงุฑููŠู† ุงู† ุงู„
191
00:16:55,210 --> 00:16:58,210
antigen antibody reaction ู‡ูˆ ุจุฑุนู†ุฉ K-unlocked
192
00:16:58,210 --> 00:17:02,350
theory ูŠุจู‚ู‰ ูˆุงุญุฏ ุจุฏู‡ ูŠูƒูˆู† ุถุจุง ูˆุงู„ุชุงู†ูŠ ู…ูุชุงุญ ูููŠู‡
193
00:17:02,350 --> 00:17:06,530
complementary structure ู„ุงุฒู… ูŠุชูƒูˆู† ุนุดุงู† ูˆุงุญุฏ ูŠุฑุชุจุท
194
00:17:06,530 --> 00:17:11,010
ููŠ ุงู„ุชุงู†ูŠ these hypervariable regions are termed
195
00:17:11,010 --> 00:17:15,710
complementary determining regionsูˆ ุจุฑู…ุฒูˆู„ู‡ู… CDR1 ูˆ
196
00:17:15,710 --> 00:17:22,710
CDR2 ูˆ CDR3 ูˆ ุงู„ู€ two-dimensional model of the
197
00:17:22,710 --> 00:17:28,310
peptide chain are brought together in the folded
198
00:17:28,310 --> 00:17:33,310
form of the intact antibody molecule ุงู„ุชู†ูŠู† ู…ุน
199
00:17:33,310 --> 00:17:36,590
ุจุนูŠุฏ ุจูŠูƒูˆู†ูˆุง ุงู„ binding sites ุงู„ู„ูŠ ุงุญู†ุง ุจู†ุญูƒูŠ
200
00:17:36,590 --> 00:17:40,050
ุนู„ูŠู‡ุง which is complementary ุชู„ุนุจุชู‡ู„ูŠุณ two
201
00:17:40,050 --> 00:17:42,750
-dimensional ูŠุนู†ูŠ ูˆุงุญุฏุฉ ู…ู† ุงู„ู€ heavy ูˆุงุญุฏุฉ ู…ู† ุงู„
202
00:17:42,750 --> 00:17:47,670
light ุงู„ุชู†ุชูŠู† ู…ุน ุจุนุถ ุจูƒูˆู†ู‡ ุงู„ู„ูŠ ู‡ูˆ folded together
203
00:17:47,670 --> 00:17:53,970
to form the complementary portion of to the EBITO
204
00:17:53,970 --> 00:17:57,390
variability
205
00:17:57,390 --> 00:18:02,330
of these CDR provide diversity ู‡ูŠ ุงู„ู„ูŠ ุจุชูˆุตู ุจุช ..
206
00:18:02,330 --> 00:18:08,020
ุจุช .. ุจุชุฃูƒุฏ ุงู† ุงูˆ ุจุช ..ุจุชุจูŠู† ู„ู†ุง ุฃูˆ ุจุชูƒูˆู† ู„ู†ุง
207
00:18:08,020 --> 00:18:13,320
ุงู„ุงุฎุชู„ุงูุงุช ุงู„ู…ุฎุชู„ูุฉ ููŠ ุงู„ุดูƒู„ between antibody
208
00:18:13,320 --> 00:18:21,100
ูˆุงู„ุงุฎุชู„ุงูุงุช ู‡ุฐู‡ ู…ุทู„ูˆุจุฉ ุนุดุงู† ุชุฑุชุจุท ุจู…ุฎุชู„ู ุฃู†ูˆุงุน ุงู„
209
00:18:21,100 --> 00:18:25,380
antigen ุงู„ู„ูŠ ู…ูˆุฌูˆุฏุฉ ูˆุจุงู„ุชุงู„ูŠ ู‡ูŠ ู…ู† ุชุดูƒู„
210
00:18:25,380 --> 00:18:30,740
specificity of antibody ู„ูƒู„ู‡ู…
211
00:18:31,300 --> 00:18:34,860
ูƒู„ ุงู„ุฑูˆุงุจุท ู„ูŠูˆู… ูŠุฑุชุจุท ุงู„ู€ Antigen ู…ุน ุงู„ู€ Antibody
212
00:18:34,860 --> 00:18:38,920
ุชูู‚ู†ุง ุนู„ู‰ ุฃู†ู‡ ููŠ ุฑูˆุงุจุท ู‡ุชุตูŠุฑ ูˆุงุญุฏุฉ ุจุชูƒู…ู„ ุงู„ุชุงู†ูŠุฉ
213
00:18:38,920 --> 00:18:42,360
ู„ูƒู† ู‡ุฐู‡ ุงู„ุฑูˆุงุจุท ู‡ูŠ ุนุจุงุฑุฉ ุนู† weak ู„ุฃู†ู‡ุง ูƒู„ู‡ุง non
214
00:18:42,360 --> 00:18:47,900
-covalent interaction ูˆู‡ุฐู‡
215
00:18:47,900 --> 00:18:51,900
ู…ู† ุงู„ู‚ุงุนุฏุฉ ุงู„ู…ู‡ู…ุฉ ุงู„ู†ู‚ุทุฉ ู‡ุฐู‡ ุงู„ู„ูŠ ุฌุงูŠุฉ ุงู†ู‡ ู…ู†
216
00:18:51,900 --> 00:18:56,090
ุงู„ู…ู…ูƒู† ุงู†ู‡ two antibodyู…ุน ุงู„ู€ two different ูŠุนู†ูŠ
217
00:18:56,090 --> 00:18:59,610
ู„ู‡ู… two different Anti-Amino Acid Sequence ูŠูƒูˆู†ูˆุง
218
00:18:59,610 --> 00:19:03,830
specific to the same Epitope ุทุจ ุดูˆ ุงู„ู„ูŠ ุจูŠุตูŠุฑ ููŠ
219
00:19:03,830 --> 00:19:08,070
ู‡ุฐู‡ ุงู„ุญุงู„ุฉุŸ ุฌุงู„ูˆุง ู…ุฑุชุจุทูˆุง ุจู†ูุณ ุงู„ู€ Antigen ู„ูƒู† ุงู„
220
00:19:08,070 --> 00:19:12,010
affinity of binding ุชุฎุชู„ู ุจูŠู†ู‡ู… ุงู„ affinity of
221
00:19:12,010 --> 00:19:21,070
binding ุชุฎุชู„ู ุจูŠู†ู‡ู… ูƒู…ุงู†
222
00:19:21,070 --> 00:19:26,590
ู‚ุงุนุฏุฉ ุฒูŠ ู…ุง ุงู†ุชูˆุง ุดุงูŠููŠู†ู‡ูŠ antibody ูˆุงุญุฏ ู‡ูˆ ู†ูุณู‡
223
00:19:26,590 --> 00:19:29,590
ุงู„ antibody ูˆุงุญุฏ ุจูŠุฑุชุจุท ุจ antigen ูˆุงุญุฏ ูˆ antigen
224
00:19:29,590 --> 00:19:37,290
ุงุชู†ูŠู† ู…ุงุดูŠ ูˆ ุทุจุนุง ู‡ุฐุง ุฒูŠ ู…ุง ู‚ู„ู†ุง ุงู„ุงุฑุชุจุงุท ู…ู…ูƒู†
225
00:19:37,290 --> 00:19:46,170
ูŠูƒูˆู† ููŠ sharing of anti of ุงุจุชูˆุจ ู„ูƒู† ุงู„ affinity
226
00:19:46,170 --> 00:19:47,610
of binding is different
227
00:19:52,180 --> 00:19:56,640
ุงู„ู€ CDR 1 ูˆ 2 ูˆ 3 ุงู„ู„ูŠ ู‡ูˆ ุฃุฎุฐ ุฌุฒุก ู…ู† .. ุนู…ู„ูˆู†ุง
228
00:19:56,640 --> 00:20:04,440
ุชุญู„ูŠู„ ุจุงู„ู€ HPLC ูˆ ูˆุฌุฏูˆุง ุงู†ู‡ ุงู„ .. ูƒู„ ู…ุง ุทู„ุนู†ุง ู„ุจุฑุง
229
00:20:04,440 --> 00:20:09,420
ุจุงู„ FAB ููŠ ู…ู†ุทู‚ุฉ ุงู„ู€ FAB region ูƒู„ ู…ุง ุงุชุฒุงุฏุช ุงู„
230
00:20:09,420 --> 00:20:13,450
hyper variabilityูƒู„ ู…ุง ุฒุงุฏุช ุงู„ variability of the
231
00:20:13,450 --> 00:20:17,270
molecule ู CDR3 ุงู„ variability ููŠู‡ุง ุงูƒุชุฑ ุญุงุฌุฉ
232
00:20:17,270 --> 00:20:23,410
ุจูŠู„ูŠู‡ุง ุงุชู†ูŠู† ุงู‚ู„ู‡ุง ูˆุงุญุฏ ุงู‚ู„ู‡ุง ูˆุงุญุฏ ุนุดุงู† ุงูŠู‡ ูƒู„ ู…ุง
233
00:20:23,410 --> 00:20:30,790
ุทู„ุนู†ุง ู„ุจุฑุง ูƒู„ ู…ุง ุฒุงุฏุช ุงู„ specificity of the
234
00:20:30,790 --> 00:20:35,390
molecule cross
235
00:20:35,390 --> 00:20:37,830
reacting compound share antigenic determinant
236
00:20:37,830 --> 00:20:42,820
ุทุจูŠุนูŠ ุฌุฏุง ู„ุงุฒู… ูŠูƒูˆู† ููŠุฅุฐุง ุตุงุฑ ููŠู‡ cross reaction
237
00:20:42,820 --> 00:20:48,480
ู…ุนู†ุงุชู‡ ููŠ sharing ููŠ ุงู„ Epitopes ู…ุงุดูŠ some cross
238
00:20:48,480 --> 00:20:53,720
reacting substances are unrelated to each other
239
00:20:53,720 --> 00:21:01,200
ุฅู„ุง ุฅู†ู‡ ุจุนุถ ุงู„ู…ุฑุงุช ุจูŠูƒูˆู† ููŠู‡ ุงุดุชุฑุงูƒ ููŠ one or more
240
00:21:01,200 --> 00:21:06,960
Epitopes in common ุงู„ู…ูˆุงุฏ
241
00:21:09,210 --> 00:21:17,290
ุงู„ู„ูŠ ู„ุง ุชุดุชุฑูƒ ุทุจุนุง ุจูŠุณู…ูˆู‡ุง ููŠ ู‡ุฐู‡ ุงู„ุญุงู„ุฉ ุงู„
242
00:21:17,290 --> 00:21:24,290
heterophilic antigen heterophil
243
00:21:24,290 --> 00:21:27,610
ู„ุฅู†ู‡ุง ุฌุงูŠุฉ ู…ู† two different species ูŠุนู†ูŠ ุนู„ู‰ ุณุจูŠู„
244
00:21:27,610 --> 00:21:31,250
ุงู„ู…ุซุงู„ human blood group antigen ุจุชุชูุงุนู„ ู…ุน
245
00:21:31,250 --> 00:21:35,070
antibody ู„ E.coli ูŠุนู†ูŠ ูŠูˆู… ูŠุตุงุจ ุงู„ุฅู†ุณุงู† ุจุงู„ E.coli
246
00:21:35,510 --> 00:21:42,190
ุงู†ููƒุดู† ูˆูŠูƒูˆู† ุงู„ุฌุณู… ุงู†ุชูŠุจุงุฏูŠ ู‡ุฐู‡ ุงู„ุงู†ุชูŠุจุงุฏูŠ ุชุชูุงุนู„
247
00:21:42,190 --> 00:21:46,570
ู…ุน blood group ุจูŠู‡ ุงู†ุชุฌู† ู…ุงุดูŠ ููŠ ู‡ุฐู‡ ุงู„ุญุงู„ุฉ
248
00:21:46,570 --> 00:21:52,810
ุงู„ุงู†ุชุฌู† of both E.coli and ุจูŠู‡ blood group ุงู†ุชุฌู†
249
00:21:52,810 --> 00:21:58,370
are ููŠู‡ similarity ู…ุงุดูŠ ููŠู‡ sharing ู„ู„AB2
250
00:22:00,170 --> 00:22:01,970
ูˆุจุงู„ุชุงู„ูŠ ุงู„ู„ู‡ู… ุตู„ู‰ ุงู„ู„ู‡ ุนู„ูŠู‡ ูˆ ุณู„ู… ูˆ ู…ุญู…ุฏ ุงู„ู„ู‡ู…
251
00:22:01,970 --> 00:22:02,150
ุตู„ู‰ ุงู„ู„ู‡ ุนู„ูŠู‡ ูˆ ุณู„ู… ูˆ ู…ุญู…ุฏ ุงู„ู„ู‡ู… ุตู„ู‰ ุงู„ู„ู‡ ุนู„ูŠู‡ ูˆ
252
00:22:02,150 --> 00:22:03,950
ุณู„ู… ูˆ ู…ุญู…ุฏ ุงู„ู„ู‡ู… ุตู„ู‰ ุงู„ู„ู‡ ุนู„ูŠู‡ ูˆ ุณู„ู… ูˆ ู…ุญู…ุฏ ุงู„ู„ู‡ู…
253
00:22:03,950 --> 00:22:04,550
ุตู„ู‰ ุงู„ู„ู‡ ุนู„ูŠู‡ ูˆ ุณู„ู… ูˆ ู…ุญู…ุฏ ุงู„ู„ู‡ู… ุตู„ู‰ ุงู„ู„ู‡ ุนู„ูŠู‡ ูˆ
254
00:22:04,550 --> 00:22:06,470
ุณู„ู… ูˆ ู…ุญู…ุฏ ุงู„ู„ู‡ู… ุตู„ู‰ ุงู„ู„ู‡ ุนู„ูŠู‡ ูˆ ุณู„ู… ูˆ ู…ุญู…ุฏ ุงู„ู„ู‡ู…
255
00:22:06,470 --> 00:22:08,090
ุตู„ู‰ ุงู„ู„ู‡ ุนู„ูŠู‡ ูˆ ุณู„ู… ูˆ ู…ุญู…ุฏ ุงู„ู„ู‡ู… ุตู„ู‰ ุงู„ู„ู‡ ุนู„ูŠู‡ ูˆ
256
00:22:08,090 --> 00:22:10,590
ุณู„ู… ูˆ ู…ุญู…ุฏ ุงู„ู„ู‡ู… ุตู„ู‰ ุงู„ู„ู‡ ุนู„ูŠู‡ ูˆ ุณู„ู… ูˆ ู…ุญู…ุฏ ุงู„ู„ู‡ู…
257
00:22:10,590 --> 00:22:10,590
ุตู„ู‰ ุงู„ู„ู‡ ุนู„ูŠู‡ ูˆ ุณู„ู… ูˆ ู…ุญู…ุฏ ุงู„ู„ู‡ู… ุตู„ู‰ ุงู„ู„ู‡ ุนู„ูŠู‡ ูˆ
258
00:22:10,590 --> 00:22:11,070
ุณู„ู… ูˆ ู…ุญู…ุฏ ุงู„ู„ู‡ู… ุตู„ู‰ ุงู„ู„ู‡ ุนู„ูŠู‡ ูˆ ุณู„ู… ูˆ ู…ุญู…ุฏ ุงู„ู„ู‡ู…
259
00:22:11,070 --> 00:22:15,950
ุตู„ู‰ ุงู„ู„ู‡ ุนู„ูŠู‡ ูˆ ุณู„ู… ูˆ ู…ุญู…ุฏ ุงู„ู„ู‡ู… ุตู„ู‰ ุงู„ู„ู‡ ุนู„ูŠู‡ ูˆ
260
00:22:15,950 --> 00:22:22,370
ุณู„ู… ูˆ
261
00:22:22,370 --> 00:22:27,870
ู…ุญู…ุฏ ุงู„ู„ู‡ู…
262
00:22:27,870 --> 00:22:34,510
ุตู„ู‰ุฃูŠุถุงู‹ ู†ุนุฑู ุฃู† ู‡ู†ุงูƒ ุงู„ุงุฎุชู„ุงูุงุช ุงู„ุฌู†ูŠุฉ ุจูŠู†
263
00:22:34,510 --> 00:22:40,450
ุงู„ุงู†ุฏููŠุฏูˆุงู„ ุจูŠู† ุงู„ุงู†ุฏููŠุฏูˆุงู„ ูŠุนู†ูŠ ุงู„ isotypes ู‡ูŠ
264
00:22:40,450 --> 00:22:43,030
ุนุจุงุฑุฉ ุนู† ุงู„ุงุฎุชู„ุงูุงุช ุงู„ู…ูˆุฌูˆุฏุฉ ููŠ ุฏุงุฎู„ ุงู„ุฅู†ุณุงู†
265
00:22:43,030 --> 00:22:46,670
ุงู„allotypes ู‡ูŠ ุงู„ุงุฎุชู„ุงูุงุช ุงู„ู…ูˆุฌูˆุฏุฉ between
266
00:22:46,670 --> 00:22:51,590
individuals of the same species ูŠุนู†ูŠ ุฃู† ู‡ู†ุงูƒ
267
00:22:51,590 --> 00:22:58,250
ุงุฎุชู„ุงูุงุช ุจูŠู† ุงู„ุงู†ุฏููŠุฏูˆุงู„ ุงู„ู„ูŠ ู…ูˆุฌูˆุฏุฉ ุจูŠู†ู‡ู…ู„ูŠุดุŸ ู„ุฃู†
268
00:22:58,250 --> 00:23:02,370
ุงู„ุฌูŠู†ุงุช ุงู„ู„ูŠ ู…ูˆุฌูˆุฏุฉ ููŠ ูƒู„ ูˆุงุญุฏ ู…ุฎุชู„ูุฉ ุนู† ุงู„ุฌูŠู†ุงุช
269
00:23:02,370 --> 00:23:06,790
ุงู„ุชุงู†ูŠุฉ. These are called Allotypic Variations.
270
00:23:07,790 --> 00:23:12,310
ุทุจุนุง ุงู„ Allotypic Differences at long loss usually
271
00:23:12,310 --> 00:23:16,390
involve changes in one or two amino acids in
272
00:23:16,390 --> 00:23:20,210
constant region.ุงุฎุชู„ุงูุงุช ุบุงู„ุจุง ุจุชูƒูˆู† ุงุฎุชู„ุงูุงุช ููŠ
273
00:23:20,210 --> 00:23:27,130
ุงู„ constant region ุชุจุนุช ุงู„ antibody.Anatopic bind
274
00:23:27,130 --> 00:23:32,670
the same antigen in similar way ุงูˆ ุงุฑุชุจุชู‡ ูˆ ุงู„
275
00:23:32,670 --> 00:23:35,770
markers ุทุจุนุง ุฒู‰ ู…ุง ู‚ู„ู†ุง ููŠู‡ ุงุฎุชู„ุงูุงุช ููŠ ุงู„ุฌูŠู† ูˆ
276
00:23:35,770 --> 00:23:39,310
ุงู„ุณุจุจ ู„ูŠุด ู„ุฅู†ู‡ ุงู„ุฌูŠู† ุจูŠูƒูˆู† ุจูŠู† ุงู„ polymorph ูุจูŠูƒูˆู†
277
00:23:39,310 --> 00:23:42,750
ููŠู‡ different ู‚ู„ูŠู„ ูˆุจุงู„ุชุงู„ูŠ ุงู„ู‚ู„ูŠู„ ุชุฏูŠู†ูŠ ุงูŠุด
278
00:23:42,750 --> 00:23:46,430
different structure ู„ูƒู† ุงู„ุงุฎุชู„ุงูุงุช ุจุชูƒูˆู† ุจุณูŠุทุฉ
279
00:23:46,430 --> 00:23:51,050
marker ู„ ุงู„ antibody ูˆุฌุฏูˆุง ุงู†ู‡ ููŠู‡ ููŠ ุงู„ุฌุนู…ุฉ chain
280
00:23:51,050 --> 00:23:57,460
ุงู„ู„ู‰ ุจุชุฏูŠู† ุงู…ูŠู†oglobulin G ููŠ GMูˆ ููŠ KM ููŠ ุงู„ู€
281
00:23:57,460 --> 00:24:02,420
Kappa Chain ูˆ ููŠ AM ููŠ ุงู„ู€ Alpha Chain ุนุดุงู† ู‡ูŠูƒ ููŠ
282
00:24:02,420 --> 00:24:08,940
ุนู†ุฏู‡ุง ุณุงูˆูŠ Classes ููŠ ุงู„ู€ G ูˆ ุงู„ู€ A Classes
283
00:24:08,940 --> 00:24:15,620
Urban Ideas are inherited in Mendelian traits ุงู„ู€
284
00:24:15,620 --> 00:24:19,780
Idiotypes ุจุชู…ุซู„
285
00:24:19,780 --> 00:24:24,500
ุงู„ุงุฎุชู„ุงูุงุช ููŠ ุงู„ู€ VL ููŠ ุงู„ูุจุฑูŠุฑูŠู… ูˆ ุงู„ู€ VH
286
00:24:27,370 --> 00:24:33,830
ูˆ ู‡ุฏูˆู„ุฉ ุฅุฐุง ูƒุงู† ุทุจุนุง ู†ู‚ู„ู†ุงู‡ู…
287
00:24:33,830 --> 00:24:41,650
ู…ู† ุฅู†ุณุงู† ุฅู„ู‰ ุฅู†ุณุงู† ูŠุนุชุจุฑูˆุง immunogenic ูˆ ูŠูƒูˆู†ูˆุง
288
00:24:41,650 --> 00:24:48,550
immune response ุทุจุนุง ุงู„ุงุฎุชู„ุงูุงุช ู‡ุฐู‡ ู…ูˆุฌูˆุฏุฉ between
289
00:24:48,550 --> 00:24:54,450
different individuals of the same speciesุนุดุงู† ู‡ูŠูƒ
290
00:24:54,450 --> 00:24:58,410
ู‡ุฐู‡ ุงู„ุธุงู‡ุฑุฉ ู…ู…ูƒู† ูŠุณุชุฎุฏู…ูˆู‡ุง by using anti-idiotypic
291
00:24:58,410 --> 00:25:05,830
structure ูˆู‡ุฐุง ู…ู…ู†ุน ุนู„ู‰ ุทูˆู„ ุงู„ antigen ูŠุนู†ูŠ ุงุชุจุงุท
292
00:25:05,830 --> 00:25:07,030
ุงู„ antibody ุจุงู„ antigen
293
00:25:11,120 --> 00:25:16,220
ู‡ุฐู‡ ุงู„ุงุฎุชู„ุงูุงุช ู„ู€ Detopic determinants ุงู„ู„ูŠ ู…ูˆุฌูˆุฏุฉ
294
00:25:16,220 --> 00:25:20,420
ููŠ ุงู„ู€ immunoglobulin ู…ู…ูƒู† ูŠูƒูˆู† ุงู„ุฃุณุงุณ ููŠ ุงู„ุชุญูƒู…
295
00:25:20,420 --> 00:25:25,700
ุจุงู„ immune response modulation ูˆู‡ูŠ ุงู„ structure
296
00:25:25,700 --> 00:25:31,680
ุชู„ุงุชุฉุฃูŠ ููŠ ุงู†ุง isotypes ุงุฎุชู„ุงู ูƒู„ู‡ ุงูŠ ุงุฎุชู„ูุช ููŠ
297
00:25:31,680 --> 00:25:37,320
ุงูŠู‡ุŸ ููŠ ุงู„ constant region ูˆุจุงู„ุชุงู„ูŠ ุฏุงู†ูŠ different
298
00:25:37,320 --> 00:25:43,200
class ูŠุนู†ูŠ ู‡ู†ุง ููŠ ุงู†ุง IGG ุงู„ constant ุนู†ุฏู‡ ู…ูุฑูˆุถ
299
00:25:43,200 --> 00:25:47,180
ุงู†ู‡ุง ุฌุงู…ุนุฉ ู…ุฎุชู„ูุฉ ุชู…ุงู…ุง ุนู† ุงู„ IGA ุงู„ู…ูุฑูˆุถ ุงู†ู‡ุง
300
00:25:47,180 --> 00:25:55,100
Alpha ุงู„ Allotype ููŠ ุดูˆูŠุฉ ุงุฎุชู„ุงูุงุช ู…ูˆุฌูˆุฏุฉ ููŠ ุงู„
301
00:25:55,100 --> 00:25:55,880
constant region
302
00:25:58,940 --> 00:26:04,540
ุงู„ุซุงู†ูŠุฉ ุฒูŠ ุจุนุถ ุงู„ู€ Minoglobulin GA ู„ูƒู† ุงู„ู€
303
00:26:04,540 --> 00:26:07,320
constant region ููŠู‡ุง ุงุฎุชู„ุงูุงุช ููŠ ุงู„ุงุดูŠุงุก ูˆู‡ุฐู‡
304
00:26:07,320 --> 00:26:12,540
ุงู„ุงุฎุชู„ุงูุงุช ู„ุง ุชุฑุฌุนู†ูŠุงุด ุนู† ูˆุฌูˆุฏ ุงู„ุงู„ูŠู„ูŠูƒ forms ููŠ
305
00:26:12,540 --> 00:26:17,960
ุงู„ุฌูŠู† ู†ูุณู‡ ุจุชุฏูŠู†ุง different form of Minoglobulin
306
00:26:17,960 --> 00:26:22,340
ุงู„ุงุฏูŠูˆ ุชุงุนูŠ ุจุงู„ุงุฎุชู„ุงู ูˆูŠู†ุŸ ู‡ุฐุง ู‡ูˆ ููŠ ุงู„ Fab region
307
00:26:23,460 --> 00:26:26,360
ุงู„ุงุฎุชู„ุงู ุจูŠู† ุงู„ู€ IgG ูˆุจุงู„ุชุงู„ูŠ ูู‰ ุนู†ุฏู†ุง different
308
00:26:26,360 --> 00:26:31,000
specific specificity ู„ูƒู† ุฒู‰ ู…ุง ู‚ู„ู†ุง ู„ูƒูˆุง ุงู†ู‡ ู‡ุฐุง
309
00:26:31,000 --> 00:26:35,000
ู„ูˆ ุงู†ุชู‚ู„ ู…ู† ุณู† ู„ุฅู†ุณุงู† it will be considered
310
00:26:35,000 --> 00:26:41,240
immunogenic immunoglobulin
311
00:26:41,240 --> 00:26:45,900
G ู‡ูˆ ุงู„ู„ู‰ ุจู†ูŠู‡ dominant immunoglobulin ูู‰ blood ูู‰
312
00:26:45,900 --> 00:26:47,720
lymph node ูู‰ lymph
313
00:26:50,550 --> 00:26:54,970
ุงู„ู€ fluid ูˆ ููŠ ุงู„ู€ CSF ุงู„ุจุฑูŠุชูˆู†ูŠุงู„ ุงู„ู€ fluid ูŠุนู†ูŠ
314
00:26:54,970 --> 00:26:59,630
ุงู„ู…ูˆุฌูˆุฏ ููŠ different types of fluid ููŠ ุงู„ุฌุณู… ูˆ
315
00:26:59,630 --> 00:27:02,190
ุบุงู„ุจุง it's distributed equally between
316
00:27:02,190 --> 00:27:05,670
intravascular and extravascular ูŠุนู†ูŠ ุงู„ู„ูŠ ููŠ ุฌูˆุง ูˆ
317
00:27:05,670 --> 00:27:11,130
ุจุฑุง ุชู‚ุฑูŠุจุง ู†ูุณ ุงู„ุญุงุฌุฉ ุจูŠุชูƒูˆู‘ู† ู…ู† two gamma wave
318
00:27:11,130 --> 00:27:18,170
chain ูˆ two lighted chain ุฅู„ุง ุฅู…ุง ูƒุงุจุง ูˆ ุฅู…ุง
319
00:27:18,170 --> 00:27:21,990
ู„ุงู…ุจุฏุงูˆู‚ู„ู†ุง ููŠ ุนู†ุฏู†ุง four sub classes ู„ู„
320
00:27:21,990 --> 00:27:27,470
immunoglobulin G ููŠ ูˆุงุญุฏ ูˆุงุซู†ูŠู† ูˆุชู„ุงุชุฉ ูˆุงุฑุจุน ูˆุงุญุฏ
321
00:27:27,470 --> 00:27:35,150
ู‡ูˆ ุงูƒุซุฑู‡ู… ุชุฑูƒูŠุฒุง ูˆ IGG sub classes ุจุชุฎุชู„ู ุจูŠู† ุจุนุถ
322
00:27:35,150 --> 00:27:40,050
ุจุงู„ chemical ูˆ biological properties ูุจู†ู„ุงู‚ูŠ ุงู†ู‡
323
00:27:40,050 --> 00:27:45,170
ุจุดูƒู„ ุนุงู… they can agglutinate or clump a
324
00:27:45,170 --> 00:27:47,050
particulate ูŠุนู†ูŠ ุงู†ุชุฌู†
325
00:27:49,560 --> 00:27:56,720
ุงู„ู€ reaction
326
00:27:56,720 --> 00:28:08,260
ุบุงู„ุจุง ู…ุน ุณูˆู„ูŠูˆู… ุงู„ุงู†ุชูŠุฌูŠู† ุจูŠุนู…ู„
327
00:28:08,260 --> 00:28:14,430
precipitate ุฅุฐุง ูƒุงู† multi-valentุงู„ุงู†ุณูˆู„ูŠุจุงู„ ุงู†ุชูŠุฌู†
328
00:28:14,430 --> 00:28:20,730
ุงู†ุชูŠุฌู† ุงู†ุชูŠุฌู† ุงู†ุชูŠุฌู† ุงู†ุชูŠุฌู† ุงู†ุชูŠุฌู† ุงู†ุชูŠุฌู† ุงู†ุชูŠุฌู†
329
00:28:20,730 --> 00:28:24,870
ุงู†ุชูŠุฌู†
330
00:28:24,870 --> 00:28:25,470
ุงู†ุชูŠุฌู† ุงู†ุชูŠุฌู† ุงู†ุชูŠุฌู† ุงู†ุชูŠุฌู† ุงู†ุชูŠุฌู† ุงู†ุชูŠุฌู† ุงู†ุชูŠุฌู†
331
00:28:25,470 --> 00:28:25,810
ุงู†ุชูŠุฌู† ุงู†ุชูŠุฌู† ุงู†ุชูŠุฌู† ุงู†ุชูŠุฌู† ุงู†ุชูŠุฌู† ุงู†ุชูŠุฌู† ุงู†ุชูŠุฌู†
332
00:28:25,810 --> 00:28:26,690
ุงู†ุชูŠุฌู† ุงู†ุชูŠุฌู† ุงู†ุชูŠุฌู† ุงู†ุชูŠุฌู† ุงู†ุชูŠุฌู† ุงู†ุชูŠุฌู† ุงู†ุชูŠุฌู†
333
00:28:26,690 --> 00:28:27,570
ุงู†ุชูŠุฌู† ุงู†ุชูŠุฌู† ุงู†ุชูŠุฌู† ุงู†ุชูŠุฌู† ุงู†ุชูŠุฌู† ุงู†ุชูŠุฌู† ุงู†ุชูŠุฌู†
334
00:28:27,570 --> 00:28:28,650
ุงู†ุชูŠุฌู† ุงู†ุชูŠุฌู† ุงู†ุชูŠุฌู† ุงู†ุชูŠุฌู† ุงู†ุชูŠุฌู† ุงู†ุชูŠุฌู† ุงู†ุชูŠุฌู†
335
00:28:28,650 --> 00:28:31,050
ุงู†ุชูŠุฌู† ุงู†ุชูŠุฌู† ุงู†ุชูŠุฌู† ุงู†ุชูŠุฌู† ุงู†ุชูŠุฌู† ุงู†ุชูŠุฌู† ุงู†ุชูŠุฌู†
336
00:28:31,050 --> 00:28:40,590
ุงู†ุชูŠุฌู† ุงู†ุชูŠุฌู† ุงู†ุชูŠุฌู†
337
00:28:40,590 --> 00:28:47,090
ุงู†ุฅุฐุง ูƒุงู† ุงู„ู€ Antibody Multivalent ูˆ ุงู„ู€ Insoluble
338
00:28:47,090 --> 00:28:52,850
ุนู„ู‰ ุทูˆู„ ูุฌูˆุฒุฉ Excel ุจุชุฎู„ุตู†ุง ู…ู†ู‡ ู…ู† ุตูุงุช ุงู„ IGG
339
00:28:52,850 --> 00:28:56,770
ู†ู‡ูˆุท Cancrosta placenta ูˆ ู‚ุงู„ูˆุง ูƒู„ู‡ู… Cancrosta
340
00:28:56,770 --> 00:29:04,970
placenta ู…ุนุงุฏุฉ IGG2 ูˆู‡ุฐุง ุทุจุนุง ุจุดูƒู„ ุงู„ู„ูŠ ู‡ูˆ
341
00:29:04,970 --> 00:29:08,190
Transferring
342
00:29:08,190 --> 00:29:14,550
immunity from mother to fetusุงู„ุชุฑุงู†ุณููŠุฑ ุงู„ุจู„ุงุณู†ุชู„
343
00:29:14,550 --> 00:29:20,290
ูŠุชู… ุฅุนุงุฏุชู‡ ู…ู† ูˆุฌูˆุฏ ู…ุตุงุฏุฑ ู…ุตุงุฏุฑ ู…ุตุงุฏุฑ ู…ุตุงุฏุฑ ู…ุตุงุฏุฑ
344
00:29:20,290 --> 00:29:20,430
ู…ุตุงุฏุฑ ู…ุตุงุฏุฑ ู…ุตุงุฏุฑ ู…ุตุงุฏุฑ ู…ุตุงุฏุฑ ู…ุตุงุฏุฑ ู…ุตุงุฏุฑ ู…ุตุงุฏุฑ
345
00:29:20,430 --> 00:29:23,450
ู…ุตุงุฏุฑ ู…ุตุงุฏุฑ ู…ุตุงุฏุฑ ู…ุตุงุฏุฑ ู…ุตุงุฏุฑ ู…ุตุงุฏุฑ ู…ุตุงุฏุฑ ู…ุตุงุฏุฑ
346
00:29:23,450 --> 00:29:24,130
ู…ุตุงุฏุฑ ู…ุตุงุฏุฑ ู…ุตุงุฏุฑ ู…ุตุงุฏุฑ ู…ุตุงุฏุฑ ู…ุตุงุฏุฑ ู…ุตุงุฏุฑ ู…ุตุงุฏุฑ
347
00:29:24,130 --> 00:29:25,150
ู…ุตุงุฏุฑ ู…ุตุงุฏุฑ ู…ุตุงุฏุฑ ู…ุตุงุฏุฑ ู…ุตุงุฏุฑ ู…ุตุงุฏุฑ ู…ุตุงุฏุฑ ู…ุตุงุฏุฑ
348
00:29:25,150 --> 00:29:27,150
ู…ุตุงุฏุฑ ู…ุตุงุฏุฑ ู…ุตุงุฏุฑ ู…ุตุงุฏุฑ ู…ุตุงุฏุฑ ู…ุตุงุฏุฑ ู…ุตุงุฏุฑ ู…ุตุงุฏุฑ
349
00:29:27,150 --> 00:29:35,270
ู…ุตุงุฏุฑ ู…ุตุงุฏุฑ ู…ุตุงุฏุฑ ู…ุตุงุฏุฑ ู…ุตุงุฏุฑ
350
00:29:35,270 --> 00:29:38,230
ู…ุต
351
00:29:40,190 --> 00:29:48,290
ููŠ ุงู„ุดู‡ุฑ ุงู„ุชุงู„ุช ุฃูˆ ุงู„ุฑุงุจุน ู…ู† ุงู„ุญู…ู„ ููŠู‡ ุฒูŠุงุฏุฉ ู…ุชุฑุฏุฎ
352
00:29:48,290 --> 00:29:56,210
ููŠ ุชุฑูƒูŠุฒ ุงู„ IGG ุงู„ู„ูŠ ุฌุงูŠ ู…ู† ุงู„ุฃู… ุนู†ุฏ ุงู„ baby ุดู‡ุฑ
353
00:29:56,210 --> 00:30:00,070
ุงู„ุฎุงู…ุณ ู…ู† ุงู„ emergency ุจุจุฏุฃ ุงู„ fetus to look after
354
00:30:00,070 --> 00:30:08,250
himself ูˆุจุงู„ุชุงู„ูŠ ุจุจุฏุฃ ูŠูƒูˆู‘ู† IgM ูˆุดูˆูŠุฉ IgA
355
00:30:11,990 --> 00:30:15,830
3 ุงูˆ 4 ุฃุดู‡ุฑ ุจุนุฏ ุงู„ูˆู„ุงุฏุฉ ุจุนุฏ ุงู„ูˆู„ุงุฏุฉ ุจุชุงู„ุชุฉ ุงุฑุจุน
356
00:30:15,830 --> 00:30:21,050
ุดู‡ูˆุฑ ุจูŠุจุฏุฃ ุงู„ infants to synthesize its own IgG
357
00:30:21,050 --> 00:30:27,390
ูˆูŠุชู‡ุงุฏุฉ ุทุจุนุง ุจูŠูƒูˆู† ู…ุณุญูˆู‚ ุจู‚ู„ุฉ drop in the
358
00:30:27,390 --> 00:30:32,890
concentration of maternal IgG absorption of
359
00:30:32,890 --> 00:30:38,750
maternal IgG ู…ูˆุฌูˆุฏ ููŠ ุงู„clostrum ุงู„clostrum of
360
00:30:38,750 --> 00:30:44,870
nursing mothers ู…ุงุดูŠูˆุทุจุนุง ุงู„ู„ูŠ ู…ูˆุฌูˆุฏ ููŠ ุงู„ cluster
361
00:30:44,870 --> 00:30:52,130
ู…ู…ูƒู† ูŠุฑุชุจุท ุจุงู„ FCRN Protection Receptor ุงู„ู„ูŠ ู…ูˆุฌูˆุฏ
362
00:30:52,130 --> 00:30:54,610
ุนู„ู‰ ุงู„ intestinal tissue of the neonate ูŠุนู†ูŠ
363
00:30:54,610 --> 00:31:01,270
ุจูŠู…ุชุตูˆุง ุงู„ baby ุงู„ุญู„ูŠุจ ุงู„ู„ูŠ ุจูŠุงุฎุฏู‡ ู…ู† ุงู„ุฃู… ููŠ IGG
364
00:31:01,270 --> 00:31:05,310
ู„ู…ุง ูŠุตู„ ุฃู…ุนุงุก ุงู„ baby ุฃูˆ ุงู„ neonate ุนู„ู‰ ุทูˆู„
365
00:31:05,310 --> 00:31:09,670
ุจูŠู…ุชุตูˆุง ู…ู† ุฎู„ุงู„ ูˆุฌูˆุฏ ุงู„ receptor FCRN ุงู„ู„ูŠ ู…ูˆุฌูˆุฏ
366
00:31:09,670 --> 00:31:16,550
ุนู„ู‰ ุงู„ intestinal tissueุณูุฉ ุฃุฎุฑู‰ ู…ู† ุตูุงุช ุงู„ IGG
367
00:31:16,550 --> 00:31:23,870
ูˆู‡ูŠ ุงู„ optionization ูˆู‡ุฐู‡ ู…ู‡ู…ุฉ ุฌุฏุง ู„ุชุณู‡ูŠู„ ุนู…ู„ูŠุฉ ุงู„
368
00:31:23,870 --> 00:31:28,230
phagocytosis ูˆุฅู„ุง ูƒูŠู ุชุชุนุฑู ุงู„ phagocytic cell ุนู„ู‰
369
00:31:28,230 --> 00:31:33,990
ุงู„ antigen ู…ู† ุฎู„ุงู„ ุชุนู„ูŠู…ู‡ by antibody mostly ุงู„
370
00:31:33,990 --> 00:31:36,570
IGG has this ability
371
00:31:42,170 --> 00:31:45,390
Antibody-dependent cell-mediated cytotoxicity
372
00:31:45,390 --> 00:31:50,810
ุจุชุนุชู…ุฏ ุนู„ู‰ ุงู† ุงู„ู€ Fabregens of IgG ุจุชุฑุชุจุท
373
00:31:50,810 --> 00:31:55,810
ุจุงู„ุฃู†ุชุฌูŠู† ุจุถุงู„ ูุงู„ุชู†ูŠู† ุงู„ู€ Fc Portion ุนู„ู‰ ุงู„ู€ Fc
374
00:31:55,810 --> 00:32:00,330
Portion ูˆุฌุฏูˆุง ุงู„ูŠู‡ ุฑูŠุณุจุชูˆุฑ ุนู„ู‰ ุณุทุญ ูƒู„ ุงู„ูุงุฌูˆุณูŠุชูƒ
375
00:32:00,330 --> 00:32:07,250
ุณูŠู„ and ุฃู†ูƒูŠ ุณูŠู„ ุนุดุงู† ู‡ูŠ ูƒู„ ุงู„ูุงุฌูˆุณูŠุชูƒ ุณูŠู„ ุชุชุนุฑู
376
00:32:07,250 --> 00:32:10,830
ุนู„ู‰ ุงู„ุงู†ุชุฌูŠู† ุจู‡ุฐู‡ ุงู„ุฎุงุตูŠุฉ ุจุงู„ุงุถุงูุฉ ุฅู„ู‰ ุงู„ู€
377
00:32:10,830 --> 00:32:19,220
Opsinizerุฃูˆ ูƒูŠููŠุฉ
378
00:32:19,220 --> 00:32:27,900
ุงู„ุชุนุฑู ุนู„ู‰ ุงู„ุงู†ุชุจุงุฏูŠ ุฏูŠ ุจู†ุฏู†ุงู„ู€ Fabregion ูˆ IGG
379
00:32:27,900 --> 00:32:31,420
ุจุชู…ุณูƒ ููŠ ุงู„ู€ Antigen ูุจุชุถู„ ูุนู„ุฉ ู…ูŠู† ุงู„ู„ูŠ ู‡ูˆ ุงู„ู€ FC
380
00:32:31,420 --> 00:32:34,900
portion ู‡ุฐุง ุงู„ู„ูŠ ู‡ูˆ ุงู„ู€ Receptor ุนู„ู‰ ุณุทุญ ุงู„ูุงุฌูˆุณ
381
00:32:34,900 --> 00:32:39,160
ุงู„ู„ูŠ ุชูƒุณุจู‡ ุงู„ู„ูŠ ุจุนุฏ ู…ุฑุฉ ุทุจุนุง ุงู„ killer cell ุชุจุฏุฃ
382
00:32:39,160 --> 00:32:46,580
ุชู‚ุชู„ ุงู„ target cell ู…ู† ุฎู„ุงู„ ุฅูุฑุงุฒ certain granules
383
00:32:46,580 --> 00:32:50,980
ุนู„ูŠู‡ุง activation of complementby IGG complement
384
00:32:50,980 --> 00:32:57,320
activation ุฃูŠุถุง ุจูŠุคุฏูŠ ุงู„ู‰ ุงู„ direct license of the
385
00:32:57,320 --> 00:33:00,980
invading organism ุจุฑุถู‡ ุจุชุชู… ู…ู† ุฎู„ุงู„ ุงู„
386
00:33:00,980 --> 00:33:07,200
optionization ูŠุนู†ูŠ ุงูŠู‡ุŸ ุจุชุชู… ุนู…ู„ูŠุฉ ุงูŠู‡ุŸ ุงู„ู„ูŠ ู‡ูˆ ุงู„
387
00:33:07,200 --> 00:33:12,340
direct killing by activation of complement
388
00:33:12,340 --> 00:33:15,930
neutralization of toxinุทุจุนุง ุจูŠุตูŠุฑ ููŠู‡ Antigen
389
00:33:15,930 --> 00:33:19,370
Antibody reaction blocking ู„ู„ุงู†ุชุฌู† ูˆ ุจูŠุตูŠุฑ ู„ู„ุชูƒุณูŠู†
390
00:33:19,370 --> 00:33:23,330
ูˆ ุจูŠุตูŠุฑ ููŠู‡ ุจูŠุตูŠุฑ ู‡ุฐุง ู‡ูˆ immunoglobulin ุจู„ู‚ุณ the
391
00:33:23,330 --> 00:33:28,870
active site of various toxins ุฒูŠ ุงู„ุชุชุงู†ุงุณ ุฒูŠ ุงู„
392
00:33:28,870 --> 00:33:33,450
portulism portulanas
393
00:33:33,450 --> 00:33:38,910
ูˆ ุงู„ passive immunization is used immobilization
394
00:33:38,910 --> 00:33:41,710
of ุจูƒุชูŠุฑูŠุง ุฒูŠ ุชุฑูŠุจุงู†ูŠู…ุงุจุงู„ูŠุฏูŠุงู…
395
00:33:46,660 --> 00:33:51,840
immobilization neutralization of virus IgG is an
396
00:33:51,840 --> 00:33:56,260
efficient virus neutralizing antibody inhibition
397
00:33:56,260 --> 00:34:01,500
of viral attachment to the target cell ูˆุทุจุนุง ุจูŠุตูŠุฑ
398
00:34:01,500 --> 00:34:07,160
ููŠู‡ inhibition ู„ู„ penetration of virus ูˆุทุจุนุง
399
00:34:07,160 --> 00:34:11,300
ุฒูŠ ู…ุง ุงู†ุชูˆุง ุดุงูŠููŠู† ุงู„ุตูˆุฑุฉู‡ูŠ ุงู„ูุงุฌูˆุณูŠุชูƒ ุณูŠู„
400
00:34:11,300 --> 00:34:16,280
ุงู„ู‡ุงุฑุณูŠุจุชูˆุฑ ู„ู„ Fc portion ู‡ูŠ ุงู„ Fc portion ุดุงูŠููŠู†
401
00:34:16,280 --> 00:34:21,920
ู…ุงุณูƒุฉ ุงู„ antibody ู…ู† ู†ุงุนุช ุงู„ Fc portion ุทุจุนุง ุงู„ Fc
402
00:34:21,920 --> 00:34:28,320
portion ุทุจุนุง ู‡ูŠ ุฒูŠ ู…ุง ุงู†ุชูˆุง ุดุงูŠููŠู† ุฒูŠ
403
00:34:28,320 --> 00:34:29,860
ู…ุง ุงู†ุชูˆุง ุดุงูŠููŠู†
404
00:34:32,840 --> 00:34:39,380
ุงู† ุงู„ุงู†ุชุฌูŠู† ู…ู„ุนู‚ ุจุงู„ุงู†ุชูŠุจุงุฏูŠ ุงู„ู„ู‰ ูุงู„ุช ู…ู†ู‡ ู…ูŠู† ุงู„
405
00:34:39,380 --> 00:34:43,000
Fc Portion ุงู„ Fc Portion ุฏู‡ ุงู„ู„ู‰ ุงู„ู„ู‰ ุฑูŠุณุจุชุฑุง ุฏู‡
406
00:34:43,000 --> 00:34:50,840
ู‡ูˆ ุนุจุงุฑุฉ ุนู† ุงู†ุชูŠุจุงุฏูŠ ุฏู‡ ู…ู…ุณูƒ ุจุงู„ Fc ุงู„ู„ู‰ ูุงู„ุช ูˆู‡ูŠ
407
00:34:50,840 --> 00:34:56,080
ู…ู…ุณูƒ ูˆุจุงู„ุชุงู„ูŠ ุจูŠุนู…ู„ุด phagocytosis ุจุชู… ุนู…ู„ูŠุชุด ุงู„
408
00:34:56,080 --> 00:34:57,020
phagocytosis
409
00:34:59,860 --> 00:35:03,400
ุงู„ู€ ุงู‡ุฏู‰ ุทุจุนุง ุงู„ important differences among human
410
00:35:03,400 --> 00:35:09,700
IGG classes ุฒู‰ ู…ุง ุชู„ุงุญุธู‰ ุงู„ IGG 1 ุงู„ุชุฑูƒูŠุฒ ุชุจุนู‡
411
00:35:09,700 --> 00:35:18,220
ุงูƒุชุฑ ูˆุงุญุฏ 70% ุจูŠุงู„ู‰ IGG 2 ุจูŠุงู„ู‰ 3 ุจูŠุงู„ู‰ 4 ุงู„ half
412
00:35:18,220 --> 00:35:27,780
life ูƒู„ู‡ู… 23 ูŠูˆู… ุจุนุฏ IGG 3 complement binding ุงู„
413
00:35:28,270 --> 00:35:32,150
ุงู„ู„ูŠ ุจูŠุนู…ู„ complement activation ู‡ูˆ IGG3 ุฃุฑุจุนุฉ
414
00:35:32,150 --> 00:35:37,910
ุจูŠุนู…ู„ุด ูˆุงุญุฏ ูˆุงุชู†ูŠู† ูŠุนู†ูŠ ุงู„ placental percentage
415
00:35:37,910 --> 00:35:42,730
ูƒู„ู‡ู… ุจูŠุนู…ู„ูˆุง crossing ู„ู„ placenta ู…ุนุงุฏุฉ IGG2 ูˆุงู„
416
00:35:42,730 --> 00:35:49,130
binding to monocytes IGG1 ูˆ 3 ุฃูƒุชุฑ ุงุชู†ูŠู† ุจูŠุนู…ู„ูˆุง
417
00:35:49,130 --> 00:35:51,370
ุงุฑุชุจุงุท ุจุงู„ monocytes
418
00:35:54,890 --> 00:35:58,470
ุงู„ู€ IgM ู‡ูˆ ุฃูˆู„ ุฃู†ุชุจุงุท ูŠุทู„ุน ูŠูˆู… ู…ุง ูŠูƒูˆู† ููŠู‡
419
00:35:58,470 --> 00:36:05,250
Infection ูˆูˆุฌูˆุฏู‡ Indicate ุงู†ู‡ ููŠู‡ Recent Infection
420
00:36:05,250 --> 00:36:10,770
ูˆู‡ูˆ ุนุจุงุฑุฉ ุนู† Pentameric Molecule ุงู„ units are
421
00:36:10,770 --> 00:36:15,950
joined together Pentameric ุฎู…ุงุณูŠ ูŠุนู†ูŠ ูˆูƒู„ unit
422
00:36:15,950 --> 00:36:18,010
ุนุจุงุฑุฉ ุนู†
423
00:36:22,480 --> 00:36:27,720
ู…ูŠู†ูˆ ุฌู„ูˆุจูŠ ุงู„ structure ูŠุนู†ูŠ ุฒูŠ ุงู„ IGG ุงู„
424
00:36:27,720 --> 00:36:33,300
structure ู„ุญุงู„ู‡ ูˆุจุงู„ุชุงู„ูŠ ุจูŠูƒูˆู† ุนู†ุฏู†ุง ุฎู…ุณุฉ
425
00:36:33,300 --> 00:36:35,680
different structure ูƒู„ ูˆุงุญุฏ ู…ู†ู‡ู… ุจูŠุณู…ูˆู‡ unit
426
00:36:35,680 --> 00:36:39,580
ุงู„ุฎู…ุณุฉ ุจูŠุฌุชู…ุนูˆุง ุจูŠุฑุชุจุทูˆุง ู…ุน ุจุนุถ ู…ู† ุฎู„ุงู„ SS bond
427
00:36:39,580 --> 00:36:42,700
ุจูŠุฑุชุจุทูˆุง
428
00:36:42,700 --> 00:36:48,180
ู…ู† ู†ุงุญูŠุฉ ุงู„ FC portion ูˆ ุจูŠูƒูˆู†ูˆุง ุงู„ J chain
429
00:36:50,720 --> 00:36:57,260
ุจุชุตู†ุน ุฃูŠุถู‹ุง ููŠ ุงู„ู€ B-Oriblasma Cell ุงู„ู€ IgM ุฃูŠุถู‹ุง
430
00:36:57,260 --> 00:37:02,060
ู…ูˆุฌูˆุฏ Intramuscular ูˆู…ูˆุฌูˆุฏ ุนู„ู‰ ุณุทุญ ุงู„ู€ B
431
00:37:02,060 --> 00:37:09,890
-Lymphocyte ูˆู‡ูˆ IGDุจูŠูƒูˆู†ูˆุง ุงู„ PCR ุงู„ู„ูŠ ู‡ูŠุฑุชุจุท
432
00:37:09,890 --> 00:37:15,190
ุจุงู„ุงู†ุชุฌู† ุงู†ุชุฌู† specific PCR ุงู„ IGM ู…ู† ุตูุงุชู‡ ุงู†ู‡
433
00:37:15,190 --> 00:37:17,930
excellent complement fixing ุจู†ุดุท ุงู„ complement
434
00:37:17,930 --> 00:37:24,690
ุจู†ุฌุงุญ ูˆ ุงูŠุถุง efficient agglutinating antibody ูˆ
435
00:37:24,690 --> 00:37:28,150
ุจูŠูƒูˆู† ุงู„ ISO hemagglutinin ูˆ ุงู„ ISO ุงู„
436
00:37:28,150 --> 00:37:31,650
hemagglutinin ู‡ู… ุนุจุงุฑุฉ ุนู† naturally occurring IGM
437
00:37:31,650 --> 00:37:37,990
antibody ู…ูˆุฌูˆุฏูŠู†against RBCs antigen ูŠุนู†ูŠ ุงู„ A B O
438
00:37:37,990 --> 00:37:43,160
antigenู„ูƒู† ุงู„ู…ุฌู„ุฏ ุงู„ู…ูˆู„ู‰ ุฃู† ุงู„ู€ IgM ุงู„ู„ูŠ ู‡ูˆ ุงู„ู€
439
00:37:43,160 --> 00:37:46,820
Isohemoglutin ู‡ุฏูˆู„ุฉ They cannot cross the placenta
440
00:37:46,820 --> 00:37:49,660
ูˆุจุงู„ุชุงู„ูŠ ู…ุง ุจูŠุนู…ู„ูˆุง incompatibility ุจูŠู† ุงู„ mother
441
00:37:49,660 --> 00:37:55,320
ูˆ ุจูŠู† ุฅูŠุด ูˆ ุจูŠู† ุงู„ fetus ุฅู„ุง ุฃู† ุจุนุถ ุงู„ุจูƒุชูŠุฑูŠุง ุงู„ู„ูŠ
442
00:37:55,320 --> 00:37:57,740
ู…ูˆุฌูˆุฏุฉ ููŠ ุงู„ gastrointestinal ุฃูˆ ุงู„ respiratory
443
00:37:57,740 --> 00:38:03,180
tract ุจูŠู„ู‡ุง ุจุนุถ ุงู„ determinants ุงู„ู„ูŠ ุจุชุดุจู‡ ุงู„ EBO
444
00:38:03,180 --> 00:38:07,920
blood group IgA
445
00:38:08,860 --> 00:38:11,440
ู‡ูˆ ุงู„ู€ major antibody ู…ูˆุฌูˆุฏ ููŠ ุงู„ู€ external
446
00:38:11,440 --> 00:38:18,720
secretion ูˆ such as saliva, mucus, sweet, gastric
447
00:38:18,720 --> 00:38:24,200
fluid and tears ูˆ ุงู„ major antibody found in
448
00:38:24,200 --> 00:38:30,840
clostrum of milk ูŠุนู†ูŠ ููŠ ุญู„ูŠุจ ุงู„ู„ุจุน ู„ู„ุฃู… and it
449
00:38:30,840 --> 00:38:35,140
protects intestinal tract of unit against pathogen
450
00:38:36,080 --> 00:38:40,160
During the first week after birth ูˆู‡ูˆ ุญุงู…ู„ ุญู…ุงู„ุฉ
451
00:38:40,160 --> 00:38:45,440
ุงู„ู€ Intestinal tract of Neonate Within mucous
452
00:38:45,440 --> 00:38:52,020
secretion ุงู„ู€ IgA ู…ูˆุฌูˆุฏ ุนู„ู‰ ุดูƒู„ ุฏุงูŠู…ุฑ ู…ุฑุชุจุท ุจู€ J
453
00:38:52,020 --> 00:38:59,840
Chain ุฒูŠ ุงู„ู€ J ุงู„ู…ูˆุฌูˆุฏุฉ ููŠู‡ ููŠ IgM ู„ูƒู† ู‡ู†ุง ุฏุงูŠู…ุฑูŠูƒ
454
00:38:59,840 --> 00:39:01,060
ู…ูˆู„ูŠูƒูˆู„ ู…ุด Pentameric
455
00:39:06,920 --> 00:39:16,080
ูˆุฎุท ุณูŠุฑ ุงู„ IGA ุนู†ุฏู…ุง ูŠุชูƒูˆู‘ู† ููŠ ุงู„ tissue ูˆูŠุฎุฑุฌ ู…ู†
456
00:39:16,080 --> 00:39:22,500
ุงู„ tissue ุนู„ู‰ ู†ูŠูˆูƒุงุณ
457
00:39:22,500 --> 00:39:29,350
ู…ุจุฑูŠู† ูŠู…ุฑ ููŠ ุงู„cellsู‡ูˆ ู…ุฑุชุจุท ุจุดูŠุก ูŠุณู…ู‰ Poly
458
00:39:29,350 --> 00:39:32,850
Immunoglobulin Receptor ู…ูˆุฌูˆุฏ ุนู„ู‰ ุงู„ู€ Basal
459
00:39:32,850 --> 00:39:36,610
Membrane of Adjacent Epithelial Cell ูˆู‡ุฐุง ุงู„ู€
460
00:39:36,610 --> 00:39:42,670
Receptor ุจุฃู‡ู„ู‡ ุฃู†ู‡ ูŠุฎุชุฑู‚ ุงู„ู€ Epithelial Cell ุนุดุงู†
461
00:39:42,670 --> 00:39:46,270
ูŠุทู„ุน Extra CellularูŠ ููŠ ุงู„ู€ Extra Cellular Fluid
462
00:39:46,270 --> 00:39:52,770
ุงู„ู„ูŠ ู…ูˆุฌูˆุฏุฉ ููŠ ุงู„ู€ Gut ุฃูˆ ุงู„ุจุฑูˆู†ูƒุงูŠ ูˆุนู…ู„ูŠุฉูˆูˆุฌูˆุฏู‡
463
00:39:52,770 --> 00:39:57,170
ุฃูŠุถู‹ุง ุจุชุชุณู‡ู‘ู„
464
00:39:57,170 --> 00:40:04,090
ุจูˆุฌูˆุฏ By enzymatic cleavage ูŠูˆู… ูŠุทู„ุน ู…ู† ุงู„ู€
465
00:40:04,090 --> 00:40:06,450
epithelial cell ุนู„ู‰ ุงู„ู€ extra cellular fluid
466
00:40:06,450 --> 00:40:11,030
ุจุชู†ู‚ุทุน ู‡ุฐู‡ ุงู„ู€ poly immunoglobulin receptor ู„ูƒู†ู‡ุง
467
00:40:11,030 --> 00:40:15,530
ุจุชุชุฑูƒ ูˆุฑุงู‡ุง ุฌุฒุก ุตุบูŠุฑ ุจุณู…ูˆู‡ secretory component
468
00:40:15,530 --> 00:40:20,190
ุจูŠุจู‚ู‰ ู…ุฑุชุจุท ุจุงู„ู€ FC portion of the immunoglobulin
469
00:40:20,190 --> 00:40:20,750
domain
470
00:40:23,640 --> 00:40:27,480
ุงู„ุฌุฒุก ุงู„ุณูŠูƒุฑุงุชูˆุฑูŠ ูŠู…ูƒู† ุฃู† ูŠุณุงุนุฏ ููŠ ุญู…ุงูŠุฉ
471
00:40:27,480 --> 00:40:30,500
ุงู„ู€Dimeric Immunoglobulin-A ู…ู† ุงู„ุชูƒุซูŠุฑ
472
00:40:30,500 --> 00:40:36,480
ุงู„ุจุฑูˆุชูŠูˆู„ูŠุชูŠูƒูŠุŒ ูŠุนู†ูŠ ุงู„ุชูƒุซูŠุฑ.ุงู„ุฌุฒุก ุงู„ุณูŠูƒุฑุงุชูˆุฑูŠ
473
00:40:36,480 --> 00:40:39,240
ูŠู…ูƒู† ุฃู† ูŠุณุงุนุฏ ููŠ ุญู…ุงูŠุฉ ุงู„ู€Respiratory and
474
00:40:39,240 --> 00:40:43,100
gastrointestinal tract ู…ู† ุงู„ุชุฃุซูŠุฑุŒ ูˆู‡ูˆ ู…ู…ูƒู† ูŠุนู…ู„
475
00:40:43,100 --> 00:40:48,280
ุงู†ู‡ูŠุจุด ู„ุฃูŠ ุฃู†ู‡ูŠุจุด ู„ุฌุณู… ุงู„ุฅุจุงุซูŠู„ูŠุง.ู‡ูˆ ุฃูŠุถู‹ุง ู…ู…ูƒู† ุฃู†
476
00:40:48,280 --> 00:40:50,840
ูŠุนู…ู„ ุงู†ู‡ูŠุจุด ู„ุฌุณู… ุงู„ุฅุจุงุซูŠู„ูŠุง.ู‡ูˆ ุฃูŠุถู‹ุง ู…ู…ูƒู† ุฃู† ูŠุนู…ู„
477
00:40:50,840 --> 00:40:51,360
ุงู†ู‡ูŠุจุด ู„ุฌุณู… ุงู„ุฅุจุงุซูŠู„ูŠุง.ู‡ูˆ ุฃูŠุถู‹ุง ู…ู…ูƒู† ุฃู† ูŠุนู…ู„
478
00:40:51,360 --> 00:40:56,300
ุงู†ู‡ูŠุจุด ู„ุฌุณู… ุงู„ุฅุจุงุซูŠู„ูŠุง.ููŠ ูˆุฌูˆุฏ ุงู„ุฅูŠุฒูˆุฒุงูŠู† ุงู„ู€ IgA
479
00:40:56,300 --> 00:40:59,920
ุฃูŠุถู‹ุง ู…ู† ุตูุงุชู‡ ุฃู†ู‡ ูŠุญุชูˆูŠ ุนู„ู‰ ุงู„ู€ Antiviral and
480
00:40:59,920 --> 00:41:06,640
Efficient Agglutinating Antibody ูˆู‡ุฐุง ู‡ูŠ ุงู„ุฑุญู„ุฉ ุฒูŠ
481
00:41:06,640 --> 00:41:13,200
ู…ุง ู‚ู„ู†ุง ุจู„ุงุฒู…ุง ุณูŠู„ ุจุชุตู†ุนู‡ ูˆูุชุดู‡ ุจูŠุตูŠุฑ as a
482
00:41:13,200 --> 00:41:16,780
diametric molecule ุทุจุนู‹ุง ุนุดุงู† ูŠู†ุชู‚ู„ ุฅู„ู‰ ุงู„ู€
483
00:41:16,780 --> 00:41:21,420
ExtracellularุจูŠุฑูˆุญ ูˆ ู‡ูˆ ู…ุฑุชุจุท ุจู€ Receptor ุนู„ู‰ ุณุทุญ
484
00:41:21,420 --> 00:41:25,730
ุงู„ู€ Adjacent Epithelial cellsูˆ ุจูŠุณู…ูˆ ู‡ุฐุง receptor
485
00:41:25,730 --> 00:41:29,330
polyminoglobulin receptor ูุจูŠุฎุด ุนู„ู‰ ุดูƒู„ physical
486
00:41:29,330 --> 00:41:33,350
ููŠ ุงู„ epithelial cells ูˆ ููŠ ุฏุงุฎู„ ุงู„ physical ุจูŠุชู…
487
00:41:33,350 --> 00:41:38,550
ุนู…ู„ูŠุฉ ุชู‚ุทูŠุนู‡ ูˆ ู„ู…ุง ุจุชู‚ุทุน ุจุทู„ุน ุทุจุนุง by enzymatic
488
00:41:38,550 --> 00:41:43,790
action ุจุทู„ุน extracellularly ุนู…ู„ูŠุฉ ุงู„ุชู‚ุทูŠุน ู…ุทู„ูˆุจุฉ
489
00:41:43,790 --> 00:41:47,970
ู„ุฃู†ู‡ big molecule ููŠ ู‡ุฐู‡ ุงู„ุญุงู„ุฉ ูุจุฏู†ุง ู†ุฒุบุฑู‡ ูˆ ุจุทู„ุน
490
00:41:47,970 --> 00:41:51,310
extracellularly ู„ูƒู† ุจูŠุจู‚ู‰
491
00:41:55,650 --> 00:42:01,330
ู…ุฑุชุจุท ุจุงู„ู€ Fc Portion of IgA Diameter ุจูŠุณู…ูˆู‡ุง ุงู„ู€
492
00:42:01,330 --> 00:42:04,550
Secretory Component ู‡ูŠ ุงู„ู„ูŠ ุจุชุญุงูุธ ุนู„ู‰ ุงู„ู…ูˆู„ูŠูƒูŠูˆู…
493
00:42:04,550 --> 00:42:10,170
ู…ู† ุงู„ุจุฑูˆุชูŠูˆู„ุงูŠุณูŠุฒ IGD
494
00:42:10,170 --> 00:42:13,830
ู…ูˆุฌูˆุฏ
495
00:42:13,830 --> 00:42:20,080
ุนู„ู‰ ุณุทุญ ุงู„ู€ P-Lymphocyte ู‡ูˆ IGMูˆ it functioned as
496
00:42:20,080 --> 00:42:26,120
antigen receptor specific PCR ุงู„ู„ูŠ ุจูŠูƒูˆู† ุงู† ุงู„ IGD
497
00:42:26,120 --> 00:42:29,360
correlate with the elimination of B cell with the
498
00:42:29,360 --> 00:42:37,180
capacity to generate self-reactive antibody ุฅูŠุด
499
00:42:37,180 --> 00:42:44,680
ูŠุนู†ูŠุŸ ูŠุนู†ูŠ ู‡ูˆ ู…ู† ูŠู…ู†ุนุฃูˆ ูŠุณุงุนุฏ ููŠ ุงู„ุชุฎู„ุต ู…ู† ุงู„ู€ B
500
00:42:44,680 --> 00:42:49,220
-Lymphocytes ุฅุฐุง ุชุญูˆู„ุช ุฅู„ู‰ ุงู„ู€ Self-Reactive ุฅุฐุง
501
00:42:49,220 --> 00:42:59,760
ุฃู†ุชุฌุช ู„ู†ุง Self-Reactive Antibody IGE ุทุจุนุง ุจูŠุณู…ูˆู‡
502
00:42:59,760 --> 00:43:05,620
Reagenic Antibody ูˆุทุจุนุง ุงู„ู€ FC Portion ุชุจุนุชู‡ ู„ู‡ุง
503
00:43:05,620 --> 00:43:12,290
ุฑูŠุณุจุชุฑ ุนู„ู‰ ุงู„ู…ุณุชู„ ูˆุงู„ุจูŠุฒูˆููŠู„ูˆู„ู…ู‘ุง ูŠุฑุชุจุท ุจุงู„ุฑุณูŠุจุชูˆุฑ
504
00:43:12,290 --> 00:43:18,530
ุชุจุนู‡ ุจุฑุชุจุท ู…ู† ุฎู„ุงู„ ุงู„ fab region ูˆููŠ
505
00:43:18,530 --> 00:43:22,750
ู‡ุฐู‡ ุงู„ุญุงู„ุฉ ุจูŠุจู‚ู‰ ุงู„ูุงู„ุฉ ุงู„ Fc portion ุงู„ู„ูŠ ู„ู…ุง
506
00:43:22,750 --> 00:43:27,450
ูŠุญุตู„ cross linking ุจุงู„ antigen ุจูŠุตูŠุฑ ุงู„ุฎู„ูŠุฉ ู‡ุฐู‡
507
00:43:27,450 --> 00:43:33,470
activated ูˆุจุชุจุฏุฃ ุชุทู„ุน ู„ู†ุงุชุญุชูˆูŠ ุนู„ู‰ ุฃูƒุชุฑ ู…ู† 24
508
00:43:33,470 --> 00:43:37,690
ุฃุดูƒุงู„ ู…ุฎุชู„ูุฉ ูƒูŠู…ูŠุงุฆูŠุฉ ุฃุดู‡ุฑู‡ุง ุงู„ู‡ูŠุณุชุงู…ูŠู† ูˆุงู„ู‡ูŠุจุงุฑูŠู†
509
00:43:37,690 --> 00:43:42,210
ูˆุงู„ูŠูˆูƒุชุฑูŠู† ูˆู‡ุฐุง ูŠุดุบู‘ู„ ุจุงู„ูุนู„ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ
510
00:43:42,210 --> 00:43:42,230
ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ
511
00:43:42,230 --> 00:43:42,890
ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ
512
00:43:42,890 --> 00:43:44,510
ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ
513
00:43:44,510 --> 00:43:46,530
ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ
514
00:43:46,530 --> 00:43:48,030
ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ
515
00:43:48,030 --> 00:43:48,030
ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ
516
00:43:48,030 --> 00:43:59,450
ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ ุนู…ู„ูŠุฉ
517
00:43:59,450 --> 00:44:05,930
ุนู…ุงุดูŠ ูŠูˆู… ูŠุฑุชุจุท ุจุงู„ุงู†ุชูŠุฌูŠู† ุจุณ ุงู„ุดุฑุท ุงู„ุฃุณุงุณูŠ ู„ุชู†ุดูŠุท
518
00:44:05,930 --> 00:44:09,670
ุงู„ุฎู„ูŠุฉ ุงู† ูŠุจู‚ู‰ ู‡ู†ุงูƒ cross linking two adjacent
519
00:44:09,670 --> 00:44:13,930
antibodies combine to the antigen ูˆุจุงู„ุชุงู„ูŠ ุจูŠุจู‚ู‰
520
00:44:13,930 --> 00:44:19,370
ู‡ู†ุงูƒ activation ูˆdegranulation ู„ู„ุฎู„ูŠุฉ ูˆุทุจุนุง ุจูŠุทู„ุน
521
00:44:19,370 --> 00:44:25,510
ุฒูŠ ู…ุง ู‚ู„ุชู„ูƒูˆุง ุงู„ู‡ุณุชุงู…ูŠู† ูˆุงู„ู‡ูŠุจุฑูŠู† ูˆุงู„ูŠูˆูƒุชุฑูŠู†
522
00:44:25,510 --> 00:44:29,210
ุจูŠุณู…ูˆู‡ ุงู„ receptor FCY
523
00:44:33,620 --> 00:44:38,980
ูˆู‡ุฐู‡ ุทุจุนุง ุงู„ู„ู‰ ู‡ู‰ ุฌุฏูˆู„ ุจูŠุจูŠู† ู„ู‰ different chemical
524
00:44:38,980 --> 00:44:43,180
and physical properties of immunoglobulins
525
00:44:43,180 --> 00:44:50,340
ุงู„ู…ุฎุชู„ูุฉ ุงู„ู„ู‰ ุณู…ูŠู†ุงู‡ู… isotopes ู‡ูˆ ู‡ู‰ ุงู„ structure
526
00:44:50,340 --> 00:44:54,000
of different isotypes ุงู„ู„ู‰ ู…ูˆุฌูˆุฏุฉ ูู‰ ุงู„ุฌุณู…
527
00:44:57,520 --> 00:45:02,620
ูˆู‡ูŠ ุงู„ figure ุงู„ู„ู‰ ู‚ูˆู„ู†ุง ูƒูŠู ุจูŠุตูŠุฑ ููŠู‡ protection
528
00:45:02,620 --> 00:45:11,920
ู„ู„ immunoglobulin IGG ููŠ ุงู„ intestinal mucosa ุฏู‡
529
00:45:11,920 --> 00:45:19,160
ู‡ูˆ ุจูŠุทู„ุน ุงู„ IGG ุจูŠุงุฎุฏู‡ ุงู„ antigen ููŠ ุงู„ FCRP ุงู„ู„ู‰
530
00:45:19,160 --> 00:45:24,540
ู‡ูˆ protection ู„ู„ FCRP ุจุฑุชุจุท ุจุงู„ antibody ุฏู‡ ู‡ูˆ ุงู„
531
00:45:24,540 --> 00:45:27,670
antibody ุงู„ู„ู‰ ู…ุงุณูƒ antigenุทุจุนุงู‹ ุจูŠุฎุด ุนู„ู‰ ุดูƒู„
532
00:45:27,670 --> 00:45:31,950
physical ุจุนุฏ ุฐู„ูƒ ุจูŠุตูŠุฑ ููŠ dissociation ู„ู„ุงู†ุชูŠุฌู† ูˆ
533
00:45:31,950 --> 00:45:36,730
ุจูŠุธู„ ุงู„ antibody ู…ุฑุชุจุท ุจุงู„ FCRP ุงู„ู„ูŠ ุจูŠุทู„ุน ุนู„ู‰ ุงู„
534
00:45:36,730 --> 00:45:44,830
cell membrane ูˆ ุจูŠุฑุชุจุท ุงู† ุจูŠุฏูˆุฑ ุนู„ู‰ ูŠุนู†ูŠ ุจูŠุญู„ ู…ู†
535
00:45:44,830 --> 00:45:49,310
ุงู„ receptor ููŠ ูˆุฌูˆุฏ neutral pH ุทุจุนุง ุงู„ antigen
536
00:45:49,310 --> 00:45:53,950
ุจูŠุธู„ ููŠ ุงู„ physical ุจุนุฏ ุฐู„ูƒ ุงู„ lysozyme ุจูŠุฎุดูˆุงู‡ูˆ
537
00:45:53,950 --> 00:45:56,690
ูŠุฎู„ุตู†ุง ู…ู† ุงู„ุงู†ุชุฌู† ู…ู† ุงู„ุงู†ุชุฌู† ุงู„ุงู†ุชุฌู† ุงู„ุงู†ุชุฌู†
538
00:45:56,690 --> 00:46:03,150
ุงู„ุงู†ุชุฌู† ุงู„ุงู†ุชุฌู† ุงู„ุงู†ุชุฌู† ุงู„ุงู†ุชุฌู† ุงู„ุงู†ุชุฌู† ุงู„ุงู†ุชุฌู†
539
00:46:03,150 --> 00:46:05,110
ุงู„ุงู†ุชุฌู† ุงู„ุงู†ุชุฌู† ุงู„ุงู†ุชุฌู† ุงู„ุงู†ุชุฌู† ุงู„ุงู†ุชุฌู† ุงู„ุงู†ุชุฌู†
540
00:46:05,110 --> 00:46:06,210
ุงู„ุงู†ุชุฌู† ุงู„ุงู†ุชุฌู† ุงู„ุงู†ุชุฌู† ุงู„ุงู†ุชุฌู† ุงู„ุงู†ุชุฌู† ุงู„ุงู†ุชุฌู†
541
00:46:06,210 --> 00:46:08,150
ุงู„ุงู†ุชุฌู† ุงู„ุงู†ุชุฌู† ุงู„ุงู†ุชุฌู† ุงู„ุงู†ุชุฌู† ุงู„ุงู†ุชุฌู† ุงู„ุงู†ุชุฌู†
542
00:46:08,150 --> 00:46:08,150
ุงู„ุงู†ุชุฌู† ุงู„ุงู†ุชุฌู† ุงู„ุงู†ุชุฌู† ุงู„ุงู†ุชุฌู† ุงู„ุงู†ุชุฌู† ุงู„ุงู†ุชุฌู†
543
00:46:08,150 --> 00:46:11,650
ุงู„ุงู†ุชุฌู† ุงู„ุงู†ุชุฌู† ุงู„ุงู†ุชุฌู† ุงู„ุงู†ุชุฌู† ุงู„ุงู†ุชุฌู† ุงู„ุงู†ุชุฌู†
544
00:46:11,650 --> 00:46:20,470
ุงู„ุงู†ุชุฌู† ุงู„ุงู†ุชุฌู† ุงู„ุงู†ุชุฌู†
545
00:46:24,680 --> 00:46:28,640
ุจุณู… ุงู„ู„ู‡ ุงู„ุฑุญู…ู† ุงู„ุฑุญูŠู… ุงุณุชูƒู…ู„ุง ู„ู…ุญุงุถุฑุฉ ุงู„ antibody
546
00:46:28,640 --> 00:46:32,800
structure and function ูˆุตู„ู†ุง ู„ ุงู„ kinetics of
547
00:46:32,800 --> 00:46:40,160
antibody response after immunization ูˆุฒูŠ ู…ุง
548
00:46:40,160 --> 00:46:42,920
ุชุดุงูŠููŠู† ููŠ ุงู„ figure ููŠ ุงู†ู‡ุง primary immune
549
00:46:42,920 --> 00:46:46,740
response ูˆ ููŠ ุงู†ู‡ุง secondary immune response ุฒูŠ ู…ุง
550
00:46:46,740 --> 00:46:49,400
ุชุดุงูŠููŠู† ููŠ ุงู„ primary immune response ููŠ ุงูƒุชุฑ ู…ู†
551
00:46:49,400 --> 00:46:53,290
phase ุจุชู…ุฑ ููŠู‡ุงุจู…ุฑ ููŠู‡ุง ุงู„ primary immune response
552
00:46:53,290 --> 00:46:56,430
ุฎู„ูŠู†ุง ู†ุชุทู„ู‚ ุฅู„ู‰ ู‡ุฐู‡ ุงู„ phases ุฒูŠ ู…ุง ุงู†ุชูˆุง ุดุงูŠููŠู†
553
00:46:56,430 --> 00:47:00,590
ููŠ ุนู†ุฏู†ุง ุงู„ู„ูŠ
554
00:47:00,590 --> 00:47:05,850
ู‡ูˆ ุงู„ latent exponential steady and declining
555
00:47:05,850 --> 00:47:13,570
ูˆู†ุดูˆูู‡ู… ุทูŠุจ ู‡ุฐู‡ ุงู„ primary phase ุจูŠู†ู‚ุณู…
556
00:47:13,570 --> 00:47:19,390
ุฅู„ู‰ ุนุฏุฉ phases ุฃูˆู„ู‡ุง ุงู„ lateูˆ ุงู„ latent ู‡ูŠ ุนุจุงุฑุฉ
557
00:47:19,390 --> 00:47:25,190
ุนู† ุงู„ lag phase ุงู„ูุชุฑุฉ ุงู„ู…ุทู„ูˆุจุฉ for B and T cell
558
00:47:25,190 --> 00:47:28,250
to make contact ูˆุตู„ู‡ุง proliferation and
559
00:47:28,250 --> 00:47:30,890
differentiation make contact ูˆ ุงู„ antigen ุทุจุนุง
560
00:47:30,890 --> 00:47:34,590
ูˆุตู„ู‡ุง proliferation and differentiation ุบุงู„ุจุง ู‡ุฐู‡
561
00:47:34,590 --> 00:47:41,230
ุงู„ูุชุฑุฉ ุจุชูƒูˆู† ู…ู† one to two weeksุงู„ูุฒ ุงู„ุชุงู†ูŠ
562
00:47:41,230 --> 00:47:43,830
exponential phase ูˆุทุจุนุง ููŠ ู‡ุฐุง ุงู„ phase ุจูŠุตูŠุฑ ููŠู‡
563
00:47:43,830 --> 00:47:47,570
ุฒูŠุงุฏุฉ ู…ู† ุงูŠู‡ ุงุณู…ู‡ ู„ู„ antibody concentration in
564
00:47:47,570 --> 00:47:51,610
serum ุงู„ูุฒ ุงู„ุชุงู„ุช ุงู„ู„ูŠ ู‡ูˆ steady phase ูˆู‡ู†ุง ุจูŠุตูŠุฑ
565
00:47:51,610 --> 00:47:55,630
ููŠู‡ balance ููŠ ุงู„ production and degradation ูˆุงุฎุฑ
566
00:47:55,630 --> 00:47:59,170
phase ู‡ูˆ declining phase ุจูŠุจุฏุฃ ุงู„ immunoglobulin
567
00:47:59,170 --> 00:48:03,070
to shutdown ูุงู„ antibody level and structure ุจูŠุตูŠุฑ
568
00:48:03,070 --> 00:48:08,290
ู„ู‡ declining rapidly ุงูˆู„ antibody ุจูŠุทู„ุน ู‡ูˆ ุงู„ IgM
569
00:48:08,910 --> 00:48:13,810
ูˆุฅุฐุง ูƒุงู† ุงู„ IGG ุจุฏูˆ ูŠุทู„ุน ูุงู„ IGG ุจูŠูƒูˆู† ู…ุตุงุญุจ ุฒูŠุงุฏุฉ
570
00:48:13,810 --> 00:48:19,270
ุงู„ IGG ุจุชูƒูˆู† ู…ุตุงุญุจู‡ุง ู‚ู„ุฉ ููŠ ุงู„ production of IGF
571
00:48:19,270 --> 00:48:22,710
ููŠ secondary immune response ุทุจุนุง ุฃุซู†ุงุก ุงู„ primary
572
00:48:22,710 --> 00:48:29,110
immune response ุชูƒูˆู† ุงู„ pool from long lived
573
00:48:29,110 --> 00:48:34,070
memory cell ุชูƒูˆู† pool of memory cell and this
574
00:48:34,070 --> 00:48:37,900
memory cellุนู†ุฏู‡ุง ุงู„ู‚ุฏุฑุฉ to mount a secondary
575
00:48:37,900 --> 00:48:43,300
response of the same antigen ููŠ secondary or
576
00:48:43,300 --> 00:48:47,240
memory response ุจูŠุณู…ูˆู‡ ุจุนุฏ ู…ุฑุงุช anamnestic
577
00:48:47,240 --> 00:48:53,420
response ุจูŠุตูŠุฑ ููŠู‡ ุทุจุนุง apparent response to the
578
00:48:53,420 --> 00:49:01,900
antigenูˆ ุบุงู„ุจุง ุจุชุชู… ููŠ ู‡ุฐุง ุงู„ response ุงู„ู„ูŠ ุจูŠูƒูˆู†
579
00:49:01,900 --> 00:49:06,580
ุงู„ lag phase is shorter ูˆ ุงู„ antibody ุงู„ู„ูŠ ุจูŠู†ุชุฌ
580
00:49:06,580 --> 00:49:15,440
ุจูŠูƒูˆู† ุฃูƒุชุฑ ูˆ it lasts longer ุจู…ุนู†ู‰ ุจุชูˆู„ for month
581
00:49:15,440 --> 00:49:20,700
or years ุงู„
582
00:49:20,700 --> 00:49:22,900
IgG antibody
583
00:49:26,730 --> 00:49:32,930
ุจุธู‡ุฑ ุจุณุฑุนุฉ ูˆุชุฑูƒูŠุฒ ุฃุนู„ู‰ ู…ู† ุงู„ู€ IgM ูˆูŠู…ูƒู† ุฃู† ูŠุทู„ุน
584
00:49:32,930 --> 00:49:36,250
IgA ุฃูˆ IgE ูˆุจูŠุณู…ูˆ ู‡ุฐู‡ ุงู„ุธุงู‡ุฑุฉ Class-Switching
585
00:49:36,250 --> 00:49:41,090
Phenomena ุจุณ ูƒู„ ุงู„ู€ Antibody ุงู„ู„ูŠ ุจุชุทู„ุน ุนุจุงุฑุฉ ุนู†
586
00:49:41,090 --> 00:49:46,070
has the same specificity as IgM ุงู„ู„ูŠ ุทู„ุน ุจุตูŠุฑ ููŠ
587
00:49:46,070 --> 00:49:48,650
affinity of maturation ููŠ ุงู„ class-switching
588
00:49:48,650 --> 00:49:51,830
ูˆุจุงู„ุชุงู„ูŠ ู‚ุฏุฑุฉ ุงู„ antibody ุงู„ู„ูŠ ุจูŠุทู„ุน ุนู„ู‰ ุงู„ุงุฑุชุจุงุท
589
00:49:51,830 --> 00:49:56,920
ุจุงู„ุงู†ุชุฌู† ุจุชูƒูˆู† ุฃุนู„ู‰ูˆ Secondary immune response
590
00:49:56,920 --> 00:50:03,820
ุจูŠู…ุซู„ ู„ู†ุง ุธุงู‡ุฑุฉ ุงู„ repeated immunization ุจู…ุนู†ู‰
591
00:50:03,820 --> 00:50:08,480
with attenuated ุทุจุนุง justified ู‡ูˆ ุจุฑุฑ ู„ู†ุง ู…ูˆุถูˆุน
592
00:50:08,480 --> 00:50:11,980
ุงู„ู„ูŠ ู‡ูˆ repeated immunization with attenuated
593
00:50:11,980 --> 00:50:16,340
inactivated pathogen to induce an immune response
594
00:50:17,310 --> 00:50:20,670
Immunoglobulin superfamily ููŠ ุนุงุฆู„ุฉ ูƒู„ู‡ุง ู‡ุฐู‡
595
00:50:20,670 --> 00:50:24,310
ุงู„ุนุงุฆู„ุฉ ูƒู„ู‡ุง ุชุดุชุฑูƒ ููŠ ุงู„ structure of
596
00:50:24,310 --> 00:50:28,670
immunoglobulin ุงู„ู„ูŠ ู‡ูˆ ุนุจุงุฑุฉ ุนู† Y-shaped ุบุงู„ุจุง ุฃูˆ
597
00:50:28,670 --> 00:50:34,550
ูˆุฌูˆุฏ ุงู„ domain ููŠ ุงู„ structure ูู‡ุฐู‡ ุงู„ุนุงุฆู„ุฉ ู‡ูŠ
598
00:50:34,550 --> 00:50:37,570
ุนุจุงุฑุฉ ุนู† immunoglobulin ุจุงุฎุฏ ุงู„ Y-shapeุงู„ู€
599
00:50:37,570 --> 00:50:41,730
Structure ุงู„ู„ู‰ ุฌู†ุจู‡ ุงู„ู„ู‰ ู‡ูˆ ุงู„ molecule ุงู„ู„ู‰ ุฌู†ุจู‡
600
00:50:41,730 --> 00:50:45,510
ุงู„ู„ู‰ ู‡ูˆ immunoglobulin Alpha, Beta, ุชูŠุฑูˆ ุฏุงูŠู…ุฑ ุฃูŠ
601
00:50:45,510 --> 00:50:49,490
ู…ุงุฎุฏ ู†ูุณ ุชู‚ุฑูŠุจุง ุงู„ structure ุซู… ุงู„ T cell receptor
602
00:50:49,490 --> 00:50:59,070
ูˆ ุงู„ CD3 CD3 ุนุจุงุฑุฉ ุนู† ุจุฑุถู‡ structure ุจูŠูƒูˆู† ุฌู†ุจ ุงู„
603
00:50:59,070 --> 00:51:07,420
PCR ูˆ immunoglobulin Alpha, BetaูˆุจูŠุณุงุนุฏ ุฃูŠุถู‹ุง ููŠ
604
00:51:07,420 --> 00:51:11,220
ุงู„ู€ Cell Signaling ุซู… Class I ูˆ Class II MHC
605
00:51:11,220 --> 00:51:15,000
ู…ูˆู„ูŠูƒูŠูˆู„ ุซู… Poly-Immunoglobulin Receptor ุงู„ู„ูŠ ู‚ู„ู†ุง
606
00:51:15,000 --> 00:51:21,660
IGA ุจุฑุชุจุท ููŠู‡ ุนุดุงู† ุชูุณูŠู„ุชูŠุช ุงู„ู„ูŠ ู‡ูˆ extravasation
607
00:51:21,660 --> 00:51:27,080
to the extracellular fluid ุงู„
608
00:51:27,080 --> 00:51:30,360
.. these molecules ุฒูŠ ู…ุง ู‚ู„ู†ุง sharing the same
609
00:51:30,360 --> 00:51:35,880
structure immunoglobulin 4-domainูˆ ุทุจุนุง ู‡ุฐุง ุฏู„ูŠู„
610
00:51:35,880 --> 00:51:40,900
ุนู„ู‰ ุงู† ูƒู„ู‡ู… ุทุงู„ุนูŠู† ู…ู† ู†ูุณ ุงู„ุฌูŠู†ุงุช ู…ู† ุฌูŠู†ุงุช ููŠ ู†ูุณ
611
00:51:40,900 --> 00:51:46,180
ุงู„ู…ู†ุทู‚ุฉ sorry ุงู„ู„ูŠ ู‡ูŠ primordial gene ุนู…ู„ูŠุฉ ุงู„
612
00:51:46,180 --> 00:51:50,190
foldingุฃูˆ ุงู„ู€ Loop Formation ูˆ ุชูƒูˆูŠู† ุงู„ู€ Domain
613
00:51:50,190 --> 00:51:55,450
ุณุจุจู‡ ุงู„ู„ูŠ ู‡ูˆ ุงู„ู€ Intra-Chain Disulfide Bond ูˆ ุงู„ู„ูŠ
614
00:51:55,450 --> 00:51:59,230
ุจูŠุดูƒู„ ุญูˆุงู„ูŠ 110 Amino Acids ูˆ ู‡ุฐู‡ ุงู„ู€ Domains
615
00:51:59,230 --> 00:52:03,810
ุบุงู„ุจุง ู‡ูŠ ุงู„ู„ุชูŠ ุชู…ูƒู† ู…ู† ุงู„ุงุฑุชุจุงุท ุจุงู„ู€ Cell Surface
616
00:52:03,810 --> 00:52:07,070
Molecule ุฒูŠ CD4 ุนู„ู‰ ุงู„ู€ T-Helper Cell ูˆ ุฃู…ุงุชุดูŠ
617
00:52:07,070 --> 00:52:10,250
Class II Molecule ุนู„ู‰ ุงู„ู€ Antigen Presenting Cell
618
00:52:10,250 --> 00:52:13,430
ุงู„ู…ูˆุถูˆุน
619
00:52:13,430 --> 00:52:15,130
ุงู„ุชุงู†ูŠ ุงู„ู„ูŠ ุจุฏุฃู†ุง ู†ุญูƒูŠ ููŠู‡ Related to
620
00:52:15,130 --> 00:52:19,040
Immunoglobulinstructure and function ู‡ูˆ ุงู„
621
00:52:19,040 --> 00:52:21,940
hybridoma technique ูˆ ุงู„ monoclonal antibody
622
00:52:21,940 --> 00:52:27,200
formation ุทุจุนุง ุฒูŠ ู…ุง ุงู†ุชูˆุง ุดุงูŠููŠู† ุงู„ุชูƒู†ูŠูƒ ุจุจุณุงุทุฉ ูˆ
623
00:52:27,200 --> 00:52:31,820
ุจุงุฎุชุตุงุฑ ุงุญู†ุง ูƒู„ ุงู„ู„ูŠ ุจู†ุงุฎุฏู‡ ู‡ูˆ ุนุจุงุฑุฉ ุนู† spleen
624
00:52:31,820 --> 00:52:40,980
cell mostly B lymphocytes ู…ู† ุงู„ spleen ุงู„ู…ู†ูุนุฑ
625
00:52:40,980 --> 00:52:46,570
ุนุฑุถู†ุง ู„ antigenูŠุนู†ูŠ ุงู„ู€ B lymphocyte already ุชุนุฑุถุช
626
00:52:46,570 --> 00:52:54,530
ู„ antigen ู…ุงุดูŠ ูˆ ุจู†ุฌูŠุจ myeloma cell ูˆ ุงู„ myeloma
627
00:52:54,530 --> 00:53:05,940
cell ุจุชูƒูˆู† ูŠุนู†ูŠ ู…ู‡ุฌู†ุฉ ุฌูŠู†ูŠุงุฃูˆ ุจุงุณุชุฎุฏุงู… ุงู„ู€ Genetic
628
00:53:05,940 --> 00:53:09,840
Engineering ุจูŠุดูŠู„ูˆุง ู…ู†ู‡ุง ุงู„ enzyme Ibogazine
629
00:53:09,840 --> 00:53:14,460
Phosphoribosyltransferase enzyme ุจูŠู†ุดุฃ ุงู„ู‡ูŠูˆ
630
00:53:14,460 --> 00:53:18,620
ู†ูŠุฌุงุชูŠู ูˆ ุจูŠุฌูŠุจูˆุง ุงู„ุชูˆุณุท ุทุจุนุง Myeloma cell ูŠุนู†ูŠ B
631
00:53:18,620 --> 00:53:24,380
lymphocyte ู„ูƒู†ู‡ุง cancer of B lymphocytes ู‡ุฐู‡
632
00:53:24,380 --> 00:53:27,980
ุงู„ุฎู„ูŠุฉ ุทุจุนุง ุดุฑุท ุงู†ู‡ุง ุชูƒูˆู† ุบูŠุฑ ู‚ุงุฏุฑุฉ ุนู„ู‰ ุฅู†ุชุงุฌ
633
00:53:27,980 --> 00:53:30,080
immunoglobulin
634
00:53:36,490 --> 00:53:41,670
ุงู„ culture media ุบุงู„ุจุง ุจูŠูƒูˆู† contain ุงู„ hat medium
635
00:53:41,670 --> 00:53:46,030
ุงู„ู„ูŠ ู‡ูˆ ุนุจุงุฑุฉ ุนู† ุงู„ hypo, ุฒู†ุซูŠู†, ุงู…ูŠู†ูˆ, ุจุชุฑูŠู†
636
00:53:47,460 --> 00:53:52,720
ูุงูŠู…ุฏูŠู†ูˆ ู…ูŠุฏูŠุงู… ุทุจุนุง ุงู„ ุจูŠู„ูŠู…ููˆุณุงูŠุช ุชุณุชุทูŠุน ุชุณุชุบู„
637
00:53:52,720 --> 00:53:58,480
ู‡ุฐู‡ ุงู„ ู†ูŠูˆูƒู„ูŠูˆุชุงูŠุฏ ู„ุชุตู†ูŠุน ุงู„ู„ูŠ ู‡ูˆ ุงู„ DNA ุจูŠู†ู…ุง ุงู„
638
00:53:58,480 --> 00:54:02,460
myeloma cell ู„ุง ุชุณุชุทูŠุน ู„ุฃู†ู‡ุง ุชูู‚ุฏ ุงู„ enzyme ุงู„ู„ูŠ
639
00:54:02,460 --> 00:54:10,680
ุจูŠุณุงุนุฏ ุนู„ู‰ ุงุณุชุบู„ุงู„ ู‡ุฐู‡ ุงู„ ู†ูŠูˆูƒู„ูŠูˆุชุงูŠุฏ ู†ุดูŠุจ ู‡ุงุช to
640
00:54:10,680 --> 00:54:15,120
grow ูˆ ุจุนุฏูŠู† ู†ูุญุต ู„ supernatant for antibody
641
00:54:15,120 --> 00:54:21,780
productionุจู†ุงุฎุฏ ุงู„ clone of each positive culture
642
00:54:21,780 --> 00:54:28,080
ูˆ ุจู†ุนู…ู„ู‡ ุฃูŠู‡ ุตุนุจ ุงู„ culturing ุจุฑุถู‡ ุจู†ูุญุต ุงู„ super
643
00:54:28,080 --> 00:54:32,960
natant ูˆ ุฅุฐุง ุจุฏู†ุง ู†ุฒูˆุฏ ุนุฏุฏู‡ุง ุฅุฐุง ุนุฌุจู†ุง ุงู„ุฎุฏูŠุฉ ูˆ
644
00:54:32,960 --> 00:54:38,560
ู†ุฌุญุช ู…ูŠุฉ ููŠ ุงู„ู…ูŠุฉ ุจู†ุฒูˆุฏ ุนุฏุฏู‡ุง ุจุฒูˆุฏ ุนุฏุฏู‡ุง ุงู…ุง by
645
00:54:39,420 --> 00:54:43,540
propagation in vivo ุฑูˆุญู†ุง ู‡ุฎู„ูŠู†ู‡ุง ุจุฑุถู‡ ููŠ
646
00:54:43,540 --> 00:54:48,140
ุงู„ุจุฑุงุชูˆู†ูŠุฑ ูƒุงูุชูŠ ุชุจุนุช ุงู„ูุนุงุฑ ูุจุชุจุฏุฃ ุชู†ู…ูˆ ุจูƒู…ูŠุงุช
647
00:54:48,140 --> 00:54:53,380
ูƒุจูŠุฑุฉ ุฌุฏุง ูˆุจูŠุนุชุจุฑ culture media ู…ุญุชุฑู… ุฌุฏุง ุงูˆ in
648
00:54:53,380 --> 00:54:57,720
vitro in subculturing ู‡ุฐุง ู‡ูˆ ู†ุนู…ู„ู‡ุง culturing
649
00:54:57,720 --> 00:55:02,940
ูˆุทุจุนุง ุจุนุฏูŠูƒ ู†ุนู…ู„ harvesting ู„ู„ู…ูˆู†ูˆูƒู„ูˆู† ุงู„ antibody
650
00:55:02,940 --> 00:55:08,160
ู†ุงุฎุฏู‡ุง ูˆ ุจู†ุนู…ู„ู‡ุง subculturing ูˆ ุจู†ุงุฎุฏุงุดุทุจุนุง ู†ุงุฎุฏ
651
00:55:08,160 --> 00:55:12,420
ูƒู„ ูˆุงุญุฏุฉ ูˆ ู†ุนู…ู„ู‡ุง ุงูŠุดุŸ ุจุชุฏูŠู†ุง clone ูˆ ุงู„ clone ุจุฏู‡
652
00:55:12,420 --> 00:55:17,240
ูŠุฏูŠู†ุง ูƒู…ูŠุงุช ูƒุจูŠุฑุฉ ู…ู† ุงู„ monoclonal antibody ุงู„ู„ูŠ
653
00:55:17,240 --> 00:55:23,080
ู‡ูŠ immunized agents ูŠูˆู… ุงูŠ ุงู†ุณุงู† ูŠุชุนุฑุถ ู„ุงู†ุชุฌู†
654
00:55:23,080 --> 00:55:26,900
ุงู„ุงู†ุชุฌู† ู…ู…ูƒู† ูŠุญุชูˆูŠ ุนู„ูŠู‡ุง many epitopes these
655
00:55:26,900 --> 00:55:31,360
epitopes will activate many lymphocytes ูˆ ุงู„
656
00:55:31,360 --> 00:55:35,180
lymphocytes ุงู„ู„ูŠ ุจุชุชู†ุดุท ู‡ุชุฏูŠู†ุง many antibodies
657
00:55:35,180 --> 00:55:40,690
specific for thedifferent epitopes ู…ุงุดูŠ ููŠ ุงู„ 75
658
00:55:40,690 --> 00:55:46,550
ูŠุนู†ูŠ ุธู‡ุฑุช ุงู„ุญุงุฌุฉ ู„ุฅู†ู‡ ู†ุญุชูˆูŠ ุนู„ู‰ monoclonal
659
00:55:46,550 --> 00:55:50,250
antibody ุจุฏู†ุงุด polyclonal ุทุจุนุง ููŠ ุงู„ .. ููŠ ุงู„ ..
660
00:55:50,250 --> 00:55:54,190
ุฃูˆู„ ู‡ุฐุง ูƒู„ ุงู„ู„ูŠ ุจูŠุทู„ุน polyclonal antibody ู„ูƒู† ุธู‡ุฑุช
661
00:55:54,190 --> 00:55:57,710
ุงู„ุญุงุฌุฉ ููŠ ุงู„ .. ุงู„ monoclonal antibody ุงู„ู„ูŠ ู‡ูˆ
662
00:55:57,710 --> 00:56:02,110
more specific ุจุณ ุจุฏู†ุง one antibodyูˆุทุจุนุง ุงู„ู„ูŠ ุฌุงู…
663
00:56:02,110 --> 00:56:06,130
ุจูŠู‡ุง ุงู„ุนู…ู„ูŠุฉ ุงู„ู„ูŠ ู‡ูˆ Kolar ูˆ Milstein ููŠ ุงู„ุฎู…ุณุฉ
664
00:56:06,130 --> 00:56:10,610
ูˆุณุจุนูŠู† ุทูˆุฑูˆุง ุนู…ู„ูŠุฉ ุชุตู†ูŠุน ุงู„ monoclonal antibody
665
00:56:10,610 --> 00:56:15,370
ูˆุงุฎุฏ ุนู„ูŠู‡ุง ุงู„ Nobel Prize ูˆ ุงู„ monoclonal antibody
666
00:56:15,370 --> 00:56:17,570
ุงู„ู„ูŠ ุจูŠุทู„ุน ู‡ูˆ ุจุฑุนู†ุฉ homogeneous population ูˆ
667
00:56:17,570 --> 00:56:20,530
antibody molecule ุทู„ุน ู…ู†ู‡ single antibody
668
00:56:20,530 --> 00:56:23,730
producing cell ูˆุงุญุฏุฉ in which all antibody are
669
00:56:23,730 --> 00:56:24,250
identical
670
00:56:30,380 --> 00:56:33,980
ูˆู‡ูŠ ุงู„ุจุฑูˆุณูŠุฌุงู„ ุงู„ู„ู‰ ุชุจุนู‡ุง ุงู„ูƒูˆูŠุฉ ุจุงู„ุถุจุท ู…ุงู„ูŠุฌู†ุฉ
671
00:56:33,980 --> 00:56:38,380
ุงู†ุชุจู„ุงุฒู…ุง ุณูŠู„ ูŠุนู†ูŠ ุงู…ูˆุฑุชุงูŠู„ ู…ุงุนู†ุฏู‡ุงุด ุงู„ู‚ุฏุฑุฉ ุงู†ู‡ุง
672
00:56:38,380 --> 00:56:43,300
ุชู†ุชุฌ ุงูŠ ู…ูŠู†ูˆ ุบู„ูˆุจูŠู„ูŠู† ู…ุงุดูŠ these cells are
673
00:56:43,300 --> 00:56:47,060
engineered to be deficient ุจูŠุดูŠู„ูˆุง ู…ู†ู‡ุง
674
00:56:47,060 --> 00:56:51,460
ุงู„hypoxanthin guanine phosphoribosyl transferase
675
00:56:51,460 --> 00:56:55,000
enzyme ูˆุจุงู„ุชุงู„ูŠ it will not survive in a culture
676
00:56:56,600 --> 00:57:02,520
ุทูˆู„ ู…ุง ุงู„ุงู†ุฒูŠู… ู‡ุฐุง ู…ุด ู…ูˆุฌูˆุฏ. These cells are
677
00:57:02,520 --> 00:57:08,020
infused ูŠุนู†ูŠ hybridized ู…ุน freshly harvested B
678
00:57:08,020 --> 00:57:13,060
lymphocyte ุฃุฎุฏู†ุงู‡ุง ู…ู† ูุนู‡ุงุŒ spleen ุชุจุน ูุนุฑ ุนุฑุถู†ุงู‡ุง
679
00:57:13,060 --> 00:57:18,160
ู„ุงู†ุชุฌู† ุณุงุจู‚ ู…ุงุดูŠ ุนู…ู„ู†ุง ู„ู‡ู… diffusion ูˆ ุงู„
680
00:57:18,160 --> 00:57:22,120
diffusion ุจุชู… ู…ู† ุฎู„ุงู„ ุฅุถุงูุฉ ู…ุงุฏุฉ ูƒูŠู…ูŠุงุฆูŠุฉ ุงุณู…ู‡ุง
681
00:57:22,120 --> 00:57:25,260
polyethylene glycol ุจุชุนู…ู„ .. ุจุณุงุนุฏ ุนู„ู‰ diffusion
682
00:57:26,770 --> 00:57:29,610
ุทุจุนุงู‹ ููŠ ู‡ุฐู‡ ุงู„ุญุงู„ุฉ ุชุฌุนู„ู†ุง ุชู„ุช ุฃู†ูˆุงุน ู…ู† ุงู„ุฎู„ุงูŠุง
683
00:57:29,610 --> 00:57:33,910
ุฎู„ุงูŠุง ุจุงู„ุฅู†ููˆุณุงูŠุช ู…ุง ุญุตู„ ู„ู‡ุงุด fusion ุซู… hybrid
684
00:57:33,910 --> 00:57:40,010
cells ุญุตู„ ู„ู‡ุง fusion ุซู… ุงู„ myeloma
685
00:57:40,010 --> 00:57:46,350
cell ุจุฑุถู‡ ู…ุง ุดุงุฑูƒุชุด ููŠ ุงู„ hybridization ู…ุงุดูŠ
686
00:57:46,350 --> 00:57:50,210
ุจู†ุญุทู‡ู… ูƒู„ู‡ู… ููŠ culture media ุดูˆ ุงู„ู„ูŠ ุจูŠุตูŠุฑ ู‚ุงู„ูˆุง
687
00:57:50,210 --> 00:57:52,890
ุงู„ antibody producing cell ุงู„ู„ูŠ ููŠ ุนู†ุฏู‡ุง
688
00:57:52,890 --> 00:57:55,710
hypoxanthinุฃูŠ ุฌูˆุงู†ูŠู†
689
00:57:55,710 --> 00:57:59,530
ููˆุณููˆุฑูŠุงุจูˆุฒูŠู„ูŠุชุฑุงู†ุณููŠุฑูŠุฒูŠูŠู†ุฒุงูŠู† ุณุชู†ุฌุญ ูˆู„ูƒู† ุงู„ุงู†ุฒูŠู†
690
00:57:59,530 --> 00:58:07,730
ู„ู† ูŠู…ูˆุช ู„ุบุงูŠุฉ ู…ุง ูŠุฎู„ุต ุญูŠุงุชู‡ ูˆ ุจุนุฏ ุฐู„ูƒ ุณุชู…ูˆุช ูˆุงู„ุณู„
691
00:58:07,730 --> 00:58:12,810
ุงู„ู…ุงู„ูŠุฌู†ุงู† ู„ุง ูŠู…ู„ูƒ ุงู†ุฒูŠู† ูˆุจุงู„ุชุงู„ูŠ ู„ู† ุชุณุชุทูŠุน ุฃู†
692
00:58:12,810 --> 00:58:18,370
ุชุตู…ุฏ ููŠ ุงู„ูƒู„ุดุฑ ูุณุชู…ูˆุช ู…ูŠู† ุจูŠุจู‚ู‰ ู„ุนูŠู†ู†ุง ุงู„ู„ูŠ ู‡ูˆ ุงู„
693
00:58:18,370 --> 00:58:24,660
hybridoma cell ู‡ุฐุง ุงู„ุณู„ ุณุชู†ุฌุญุทุจุนุง ู‡ุฐู‡ ู…ู…ูƒู† ู†ูุญุตู‡ุง
694
00:58:24,660 --> 00:58:29,660
ุจุจุณุงุทุฉ ู†ูุญุต ุงู„ supernatant ุชุจุนู‡ุง by ุฃูˆ ุงู„ antibody
695
00:58:29,660 --> 00:58:37,820
producing ู…ู†ู‡ุง by ELISA technique and those cells
696
00:58:37,820 --> 00:58:44,120
are cloned ูˆูƒู„ clone ู…ู…ูƒู† ุชูƒูˆู† ุงู†ู‡ุง ูƒู…ูŠุฉ ูƒุจูŠุฑุฉ ู…ู†
697
00:58:44,120 --> 00:58:47,180
ุงู„ monoclonal antibody with a single specificity
698
00:58:48,410 --> 00:58:51,290
ุงุณุชุฎุฏุงู… ุงู„ู€ Monoclonal Antibody ุบุงู„ุจุง ุชุณุชุฎุฏู… ููŠ
699
00:58:51,290 --> 00:58:55,510
ุงู„ู€ Diagnostic Technique ูˆูƒู„ ูุนุดุงุทู†ุง ููŠ ุงู„ู…ุฎุชุจุฑ
700
00:58:55,510 --> 00:59:00,830
ุชุนุชู…ุฏ ุนู„ู‰ ุงู„ู€ Monoclonal Antibody ุงู„ู€ agent ูƒู„ู†ุง
701
00:59:00,830 --> 00:59:04,330
ูƒู„ ุงู„ูƒุชุงุช ุงู„ู„ูŠ ุจู†ุณุชุฎุฏู…ู‡ุง ุบุงู„ุจุง ู‡ูŠ Monoclonal
702
00:59:04,330 --> 00:59:08,610
Antibody ุงู„ุฃุบู„ู‰ ู…ู†ู‡ุง ู‡ูŠ ุนุจุงุฑุฉ ุนู† Monoclonal
703
00:59:08,610 --> 00:59:10,670
Antibody ุทุจุนุง ุงู„ Polycloma ุงู„ู„ูŠ ุจูŠุฏูŠู†ุง cross
704
00:59:10,670 --> 00:59:16,770
reactivity ูˆู…ุด .. ูˆ non specific ุฃูŠุถุง ุชุณุชุฎุฏู… ููŠ ุงู„
705
00:59:16,770 --> 00:59:22,890
treatmentof cancer ุดูˆ ุงู„ู„ูŠ ุจูŠุนู…ู„ูˆู‡ ุงู„ูŠูˆู… ุจูŠุฑุจุทูˆู‡
706
00:59:22,890 --> 00:59:26,530
ููŠ ุฏูŠุงู„ ุงู„ monoclonal antibody ุงู„ drug ุงูˆ ุงู„ toxin
707
00:59:26,530 --> 00:59:30,270
ูˆ ุจูŠุญู‚ู†ูˆู‡ ููŠ ุงู„ู…ุฑูŠุถ ุจูŠุถู„ ูŠุฌุฑูŠ ูŠุฌุฑูŠ ูŠุฌุฑูŠ ู„ุบุงูŠุฉ ู…ุง
708
00:59:30,270 --> 00:59:33,890
ูŠุตู„ ุงู„ tumor cell ุงูˆ ุงู„ infected cell ูˆ ู‡ู†ุงูƒ ุจูŠู…ุณูƒ
709
00:59:33,890 --> 00:59:39,070
ููŠู‡ุง ูˆ ุงู„ toxin ุงู„ู…ุฑุจูˆุท ููŠู‡ุง ุงูˆ ุงู„ drug ุจุนู…ู„ ุนู…ู„ูŠุฉ
710
00:59:39,070 --> 00:59:43,210
ู‚ุชู„ ู„ู‡ุง ูˆ ุจุงู„ุชุงู„ูŠ ุจูŠุตูŠุฑ ููŠ targeting therapy
711
00:59:43,210 --> 00:59:47,510
ุจูŠุณู…ูˆู‡ุง ุงู„ุนู…ู„ูŠุฉ targeting therapy
712
00:59:49,380 --> 00:59:55,480
ุจู‡ูŠูƒ ุจู†ูƒูˆู† ุงู† ู‡ู†ุง ุงู„ู…ุญุงุถุฑุฉ ุงุชู…ู†ู‰ ุงู† ุชูƒูˆู†ูˆุง ูŠุนู†ูŠ ู‚ุฏ
713
00:59:55,480 --> 00:59:58,320
ุงุณุชูุฏุชู… ุงู† ุดุงุก ุงู„ู„ู‡ ูˆ ุดูƒุฑุง